{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "[leiden algo documentation](https://leidenalg.readthedocs.io/en/latest/install.html)\n",
    "\n",
    "# General Approach\n",
    "\n",
    "In this analysis, we explore the clustering of scientific publications using the Leiden algorithm, with a focus on adjusting the algorithm's parameters to improve the coherence and relevance of the clusters formed. The Leiden algorithm, which improves upon the limitations of modularity optimization seen in previous methods, is employed for its effectiveness in identifying communities within networks. We particularly experiment with various resolution parameters, iterating through a range of values to tune the granularity of the clustering results. The objective is to find an optimal balance where clusters are neither too broad, encompassing multiple unrelated topics, nor too narrow, breaking down coherent subjects into excessive subgroups.\n",
    "\n",
    "The analysis starts with the application of the Leiden algorithm using default settings and then progresses to more sophisticated implementations, including adjusting the resolution parameter to influence the size and coherence of clusters. This parameter tuning is crucial for addressing the resolution limit problem inherent in modularity-based community detection methods. By carefully selecting resolution parameters, we aim to achieve a set of clusters that are meaningful and manageable for qualitative analysis.\n",
    "\n",
    "This process is supported by the creation of summary sheets and detailed exploratory sheets for each parameter set, facilitating a thorough review of the clustering outcomes. Parameters leading to the most coherent and distinct clusters, based on predefined decision criteria, are identified and selected for further analysis. The final selection of parameters is based on qualitative assessments of cluster coherence, ensuring that the clusters formed are both scientifically relevant and insightful for further research explorations.\n",
    "\n",
    "Notes about the leiden algorithm:\n",
    "\n",
    "### The most simpe implementation is this:\n",
    "\n",
    "Here we would just use all default parameters.\n",
    "The metrices are good, the qualitative assessment poor.\n",
    "The `ModularityVertexPartition` is the default partitioning algorithm\n",
    "\n",
    "- it is based on the modularity measure (link density within communities vs. link density between communities)\n",
    "- Higher scires = stronger division into communities\n",
    "- It tries to maximize the modularity score\n",
    "\n",
    "The problem here is that the partitions are really big (if run without max_comm_size, around 5,000 papers in the largest communit)\n",
    "Examining the most central articles (based on the eigenvector similarity), they do not seem coherent.\n",
    "\n",
    "**PROBLEM:** Modularity, though\n",
    "robust for many practical applications, suffers from the resolution limit problem,\n",
    "in which optimization may fail to identify clusters smaller than a certain scale\n",
    "that is dependent on properties of the network. (https://arxiv.org/pdf/2308.09644.pdf)\n",
    "\n",
    "### The second implementation is this:\n",
    "\n",
    "We are trying to tune the resolution parameter. To access it, we use the CPMVertexPartition algorithm. (CPM = Constant Potts Model)\n",
    "This means that modularity is not an important parameter anymore.\n",
    "\n",
    "- The resolution parameter is the only parameter of this algorithm\n",
    "- It compares the actual link density to the resolution parameter\n",
    "- If the link density is higher than the resolution parameter, the nodes are put into the same community\n",
    "- It has a quality attribute, which is similar to the modularity score\n",
    "- We will not rely on this but use a qualitative analysis to assess the results\n",
    "\n",
    "In previous papers (Waltman 2020a, Ahlgren 2020), the authors used different levels of granularity. They used 10 different values of the resolution parameter γ: 0.000001, 0.000002, 0.000005, 0.00001, 0.00002, 0.00005, 0.0001, 0.0002, 0.0005, 0.001, 0.002, 0.005, 0.01\n",
    "\n",
    "We decide to use the following resolution parameter to narrow down our search.\n",
    "0.00001,0.00002,0.0001,0.0002,0.001,0.002,0.01,0.02,\n",
    "\n",
    "We then evaluated the solutions\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Packages\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The autoreload extension is already loaded. To reload it, use:\n",
      "  %reload_ext autoreload\n"
     ]
    }
   ],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "import pandas as pd\n",
    "import networkx as nx\n",
    "import leidenalg as la\n",
    "import igraph as ig\n",
    "import sys\n",
    "import glob\n",
    "from tqdm import tqdm\n",
    "\n",
    "sys.path.append(\"/Users/jlq293/Projects/Study-1-Bibliometrics/src/network/\")\n",
    "from creation.PartitionCreator import PartitionCreator\n",
    "from analysis.NetworkAnalyzer import CommunityExplorer, FullExplorer\n",
    "from analysis.NetworkAnalyzerUtils import NetworkAnalyzerUtils"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# load df and graphs\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['alpha0.3_k10', 'alpha0.3_k15', 'alpha0.3_k20', 'alpha0.3_k5', 'alpha0.5_k10', 'alpha0.5_k15', 'alpha0.5_k20', 'alpha0.5_k5', 'alpha0.6_k20'])\n"
     ]
    }
   ],
   "source": [
    "# load all files in a dictionary with params as keys and graph as values\n",
    "\n",
    "params_graph_dict, df = NetworkAnalyzerUtils().load_graph_files()\n",
    "\n",
    "print(params_graph_dict.keys())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[\"title_abstract\"] = df.apply(\n",
    "    lambda x: (\n",
    "        x[\"title\"] + \". \" + str(x[\"abstract\"])\n",
    "        if pd.notnull(x[\"abstract\"])\n",
    "        else x[\"title\"]\n",
    "    ),\n",
    "    axis=1,\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# CPM RESOLUTION DETERMINATION\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# waltman 2020a:\n",
    "\n",
    "Different levels of granularity were considered. For each relatedness measure, we obtained 10 clustering solutions, each of them for a different value of the resolution parameter γ. The following values of γ were used: 0.00001, 0.00002, 0.00005, 0.0001, 0.0002, 0.0005, 0.001, 0.002, 0.005, and 0.01.\n",
    "\n",
    "# ahlgren 2020:\n",
    "\n",
    "Using different values of the resolution parameter γ (0.000001, 0.000002, 0.000005, 0.00001, 0.00002, 0.00005, 0.0001, 0.0002, 0.0005, 0.001, 0.002), we obtain 11 clustering solutions for each relatedness measure. Compared to our earlier study (Ahlgren et al., 2019), we exclude the clustering solutions for the two largest resolution values used in that study (0.005 and 0.01). These clustering solutions have around 300,000 and 500,000 clusters, respectively, and most of the clusters consist of fewer than 10 publications.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "def process_params_graph_dict(params_graph_dict):\n",
    "    \"\"\"\n",
    "    Process the parameters and graph dictionary.\n",
    "\n",
    "    Args:\n",
    "        params_graph_dict (dict): A dictionary containing the parameters and corresponding graph.\n",
    "\n",
    "    Returns:\n",
    "        tuple: A tuple containing the overall summary DataFrame and the explorer sheets dictionary.\n",
    "    \"\"\"\n",
    "    # Define the resolution values to iterate over\n",
    "    resolution_values = [\n",
    "        0.000001,\n",
    "        0.000002,\n",
    "        0.000005,\n",
    "        0.00001,\n",
    "        0.00002,\n",
    "        0.00005,\n",
    "        0.0001,\n",
    "        0.0002,\n",
    "        0.0005,\n",
    "        0.001,\n",
    "        0.002,\n",
    "        0.005,\n",
    "        0.006,\n",
    "        0.01,\n",
    "        0.02,\n",
    "    ]\n",
    "    iterations = -1  # until a partition is not an improvement over the previous one\n",
    "    overall_summary_dict = {\n",
    "        \"KNN-Params\": [],\n",
    "        \"Resolution\": [],\n",
    "        \"Nr of Clusters\": [],\n",
    "    }\n",
    "    explorer_sheets_dict = {}\n",
    "\n",
    "    # Iterate over each graph and resolution value\n",
    "    for params, G in tqdm(params_graph_dict.items(), desc=\"Processing graphs\"):\n",
    "        for resolution in resolution_values:\n",
    "            # Create partition using CPMVertexPartition algorithm\n",
    "            pc = PartitionCreator(G, df)\n",
    "            pc.create_partition_from_cmpvertexpartition(\n",
    "                n_iterations=iterations,\n",
    "                resolution_parameter=resolution,\n",
    "                verbose=False,\n",
    "                cluster_column_name=f\"cluster_{params}_res{resolution}\",\n",
    "            )\n",
    "\n",
    "            ## Explore communities using CommunityExplorer\n",
    "            fe = FullExplorer(\n",
    "                df=pc.df,\n",
    "                cluster_column=f\"cluster_{params}_res{resolution}\",\n",
    "                params=params,\n",
    "                resolution=resolution,\n",
    "            )\n",
    "            single_summary_dict = fe.summary_dict_creator()\n",
    "            for k, v in single_summary_dict.items():\n",
    "                overall_summary_dict[k].append(v)\n",
    "            params_df = fe.explorer_sheets_creator()\n",
    "            explorer_sheets_dict[f\"{params}_res{resolution}\"] = params_df\n",
    "\n",
    "    # Create a DataFrame with the graph parameters and the number of clusters\n",
    "    overall_summary_df = pd.DataFrame(overall_summary_dict).sort_values(\n",
    "        by=\"Nr of Clusters\", ascending=False\n",
    "    )\n",
    "    return overall_summary_df, explorer_sheets_dict"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Full Partitions and Resolution Explorer\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing graphs: 100%|██████████| 9/9 [1:20:37<00:00, 537.44s/it]\n"
     ]
    }
   ],
   "source": [
    "overall_summary_df, explorer_sheets_dict = process_params_graph_dict(params_graph_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "# save limited_df_graph_cluster_params as first sheet\n",
    "filepath = \"../output/cluster-qualifications/cluster-explorer/01-FullParameterFinder_ClusterExplorer.xlsx\"\n",
    "\n",
    "NetworkAnalyzerUtils().params_excel_saver_with_hyperlinks(\n",
    "    filepath, overall_summary_df, explorer_sheets_dict\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# restrict min and max of clusters\n",
    "\n",
    "min 50 and max 500 clusters\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Full partitions_explorer_dict: 135\n",
      "filtered partitions_explorer_dict: 42\n"
     ]
    }
   ],
   "source": [
    "filtered_overall_summary_df = overall_summary_df[\n",
    "    (overall_summary_df[\"Nr of Clusters\"] > 50)\n",
    "    & (overall_summary_df[\"Nr of Clusters\"] < 500)\n",
    "]\n",
    "\n",
    "params_to_keep = (\n",
    "    filtered_overall_summary_df[\"KNN-Params\"]\n",
    "    + \"_res\"\n",
    "    + filtered_overall_summary_df[\"Resolution\"].astype(str)\n",
    ")\n",
    "\n",
    "filtered_explorer_sheets_dict = {k: explorer_sheets_dict[k] for k in params_to_keep}\n",
    "\n",
    "\n",
    "print(f\"Full partitions_explorer_dict: {len(overall_summary_df)}\")\n",
    "print(f\"filtered partitions_explorer_dict: {len(filtered_overall_summary_df)}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "# save limited_df_graph_cluster_params as first sheet\n",
    "filepath = \"../output/cluster-qualifications/cluster-explorer/02-FilteredParameterFinder_ClusterExplorer.xlsx\"\n",
    "\n",
    "NetworkAnalyzerUtils().params_excel_saver_with_hyperlinks(\n",
    "    filepath, filtered_overall_summary_df, filtered_explorer_sheets_dict\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Limit Parameter Space\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Decision Criteria:\n",
    "\n",
    "1. premature ejaculation and sexual dysfunction be distinct clusters\n",
    "2. Mixing of anxiety and panic disorder?\n",
    "3. Diabetic Mice VS Body Weight and Diabetes VS depression treatment in diabetics?\n",
    "4. Use alpha = 0.3 (look at alpha0.5_k10_res0.002); topics: 50, 133 -> very mixed words, little coherence.Not the case for alpha0.3_k10_res0.002 (here, sexual dys and premature ejac single topic though)\n",
    "5. Zimeldine (1 or two topics)\n",
    "6. Pregnancy related topics.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "keepornot = {\n",
    "    # all k=5 have many many clusters of single papers\n",
    "    \"alpha0.5_k5_res1e-05\": 0,\n",
    "    \"alpha0.5_k5_res2e-05\": 0,\n",
    "    \"alpha0.5_k5_res0.0001\": 0,\n",
    "    \"alpha0.5_k5_res0.0002\": 0,\n",
    "    \"alpha0.5_k5_res0.001\": 0,\n",
    "    \"alpha0.5_k5_res0.002\": 0,\n",
    "    \"alpha0.5_k5_res0.006\": 0,\n",
    "    \"alpha0.5_k5_res0.01\": 0,\n",
    "    \"alpha0.5_k5_res0.02\": 0,\n",
    "    # K10\n",
    "    \"alpha0.5_k10_res1e-05\": 0,\n",
    "    \"alpha0.5_k10_res2e-05\": 0,\n",
    "    \"alpha0.5_k10_res0.0001\": 0,\n",
    "    \"alpha0.5_k10_res0.0002\": 0,\n",
    "    \"alpha0.5_k10_res0.001\": 0,  # premature ejaculation and sexual dysfunction and one topic\n",
    "    \"alpha0.5_k10_res0.002\": 0,  # weight and sex are one topic, same problem as above\n",
    "    \"alpha0.5_k20_res0.005\": 1,\n",
    "    \"alpha0.5_k10_res0.006\": 0,\n",
    "    \"alpha0.5_k10_res0.01\": 0,\n",
    "    \"alpha0.5_k10_res0.02\": 0,\n",
    "    # K15\n",
    "    \"alpha0.5_k15_res1e-05\": 0,\n",
    "    \"alpha0.5_k15_res2e-05\": 0,\n",
    "    \"alpha0.5_k15_res0.0001\": 0,\n",
    "    \"alpha0.5_k15_res0.0002\": 0,\n",
    "    \"alpha0.5_k15_res0.001\": 0,  # no bad, very broad and inclusive topics\n",
    "    \"alpha0.5_k15_res0.002\": 0,  # gut sex dysf and premature ejaculation are one topic\n",
    "    \"alpha0.5_k15_res0.006\": 1,  # pretty good. bit too many. too many pregnancy clusters, for example\n",
    "    \"alpha0.5_k15_res0.01\": 0,\n",
    "    \"alpha0.5_k15_res0.02\": 0,\n",
    "    # K20\n",
    "    \"alpha0.5_k20_res1e-05\": 0,\n",
    "    \"alpha0.5_k20_res2e-05\": 0,\n",
    "    \"alpha0.5_k20_res0.0001\": 0,\n",
    "    \"alpha0.5_k20_res0.0002\": 0,\n",
    "    \"alpha0.5_k20_res0.001\": 0,\n",
    "    \"alpha0.5_k20_res0.002\": 0,\n",
    "    \"alpha0.5_k20_res0.005\": 1,\n",
    "    \"alpha0.5_k20_res0.006\": 1,\n",
    "    \"alpha0.5_k20_res0.01\": 1,  # MANY MANT HT TOPCIS (something betwe 002 and 01 needed.)\n",
    "    \"alpha0.5_k20_res0.02\": 0,\n",
    "    # NEW ALPHA 0.3\n",
    "    # K5\n",
    "    \"alpha0.3_k5_res1e-05\": 0,\n",
    "    \"alpha0.3_k5_res2e-05\": 0,\n",
    "    \"alpha0.3_k5_res0.0001\": 0,\n",
    "    \"alpha0.3_k5_res0.0002\": 0,\n",
    "    \"alpha0.3_k5_res0.001\": 0,\n",
    "    \"alpha0.3_k5_res0.002\": 0,\n",
    "    \"alpha0.3_k5_res0.006\": 0,\n",
    "    \"alpha0.3_k5_res0.01\": 0,\n",
    "    \"alpha0.3_k5_res0.02\": 0,\n",
    "    # K10\n",
    "    \"alpha0.3_k10_res1e-05\": 0,\n",
    "    \"alpha0.3_k10_res2e-05\": 0,\n",
    "    \"alpha0.3_k10_res0.0001\": 0,\n",
    "    \"alpha0.3_k10_res0.0002\": 0,\n",
    "    \"alpha0.3_k10_res0.001\": 0,  # premature ejaculation and sexual dysfunction and one topic; anxiety + panic too\n",
    "    \"alpha0.3_k10_res0.002\": 1,  # good\n",
    "    \"alpha0.3_k20_res0.005\": 1,  # ok good\n",
    "    \"alpha0.3_k10_res0.006\": 1,\n",
    "    \"alpha0.3_k10_res0.01\": 0,  # good illustration for granularity using 'suicide' (500 topics)\n",
    "    \"alpha0.3_k10_res0.02\": 0,\n",
    "    # K15\n",
    "    \"alpha0.3_k15_res1e-05\": 0,\n",
    "    \"alpha0.3_k15_res2e-05\": 0,\n",
    "    \"alpha0.3_k15_res0.0001\": 0,\n",
    "    \"alpha0.3_k15_res0.0002\": 0,\n",
    "    \"alpha0.3_k15_res0.001\": 0,  # no bad, very broad and inclusive topics\n",
    "    \"alpha0.3_k15_res0.002\": 0,  # gut sex dysf and premature ejaculation are one topic\n",
    "    \"alpha0.3_k15_res0.006\": 1,  # pretty good. bit too many. too many pregnancy clusters, for example\n",
    "    \"alpha0.3_k15_res0.01\": 1,  # good illustration for granularity using 'suicide' (500 topics)\n",
    "    \"alpha0.3_k15_res0.02\": 0,\n",
    "    # K 20\n",
    "    \"alpha0.3_k20_res1e-05\": 0,\n",
    "    \"alpha0.3_k20_res2e-05\": 0,\n",
    "    \"alpha0.3_k20_res0.0001\": 0,\n",
    "    \"alpha0.3_k20_res0.0002\": 0,\n",
    "    \"alpha0.3_k20_res0.001\": 0,\n",
    "    \"alpha0.3_k20_res0.002\": 0,  # too few?\n",
    "    \"alpha0.3_k20_res0.005\": 1,  # best ?\n",
    "    \"alpha0.3_k20_res0.006\": 1,  # best ?\n",
    "    \"alpha0.3_k20_res0.01\": 1,  # too many? aber gut.\n",
    "    \"alpha0.3_k20_res0.02\": 1,\n",
    "}"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### save limit param space to excel\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/6m/zjbwrdgj0bg9zyhx3l7134mm0000gn/T/ipykernel_37664/2876100044.py:7: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  filtered_overall_summary_df[\"keep\"] = filtered_overall_summary_df.apply(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Nr of soltions initially: 135\n",
      "Nr of solutions after filtering: 42\n",
      "Nr of solutions after double filtering: 11\n"
     ]
    }
   ],
   "source": [
    "# Filter explorer_sheets_dict based on keepornot values\n",
    "double_filtered_explorer_sheets_dict = {\n",
    "    k: v for k, v in filtered_explorer_sheets_dict.items() if keepornot.get(k, 0) == 1\n",
    "}\n",
    "\n",
    "# Create a 'drop' flag directly in the filtering step to avoid extra column manipulation\n",
    "filtered_overall_summary_df[\"keep\"] = filtered_overall_summary_df.apply(\n",
    "    lambda row: keepornot.get(f\"{row['KNN-Params']}_res{row['Resolution']}\", 0), axis=1\n",
    ")\n",
    "double_filtered_overall_summary_df = filtered_overall_summary_df[\n",
    "    filtered_overall_summary_df[\"keep\"] == 1\n",
    "].drop(columns=[\"keep\"])\n",
    "\n",
    "# Save filtered data and sheets\n",
    "filepath = \"../output/cluster-qualifications/cluster-explorer/03-ManuallyLimitedParameterFinder_ClusterExplorer.xlsx\"\n",
    "\n",
    "# Assuming NetworkAnalyzerUtils() and its method are properly defined\n",
    "# and can handle saving a DataFrame with hyperlinks\n",
    "NetworkAnalyzerUtils().params_excel_saver_with_hyperlinks(\n",
    "    filepath, double_filtered_overall_summary_df, double_filtered_explorer_sheets_dict\n",
    ")\n",
    "\n",
    "print(f\"Nr of soltions initially: {len(overall_summary_df)}\")\n",
    "print(f\"Nr of solutions after filtering: {len(filtered_overall_summary_df)}\")\n",
    "print(\n",
    "    f\"Nr of solutions after double filtering: {len(double_filtered_overall_summary_df)}\"\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Looking at individual solutions\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Params: alpha0.3_k15_res0.01; Nr of clusters: 385\n",
      "##################################################\n",
      "Params: alpha0.5_k20_res0.01; Nr of clusters: 369\n",
      "##################################################\n",
      "Params: alpha0.3_k10_res0.006; Nr of clusters: 368\n",
      "##################################################\n",
      "Params: alpha0.3_k20_res0.01; Nr of clusters: 298\n",
      "##################################################\n",
      "Params: alpha0.5_k15_res0.006; Nr of clusters: 290\n",
      "##################################################\n",
      "Params: alpha0.3_k15_res0.006; Nr of clusters: 246\n",
      "##################################################\n",
      "Params: alpha0.5_k20_res0.006; Nr of clusters: 226\n",
      "##################################################\n",
      "Params: alpha0.3_k20_res0.006; Nr of clusters: 192\n",
      "##################################################\n",
      "Params: alpha0.5_k20_res0.005; Nr of clusters: 190\n",
      "##################################################\n",
      "Params: alpha0.3_k20_res0.005; Nr of clusters: 162\n",
      "##################################################\n",
      "Params: alpha0.3_k10_res0.002; Nr of clusters: 147\n",
      "##################################################\n"
     ]
    }
   ],
   "source": [
    "iterations = -1  # until a partition is not an improvement over the previous one\n",
    "quality_values = []\n",
    "nr_clusters = []\n",
    "partitions = []\n",
    "graph_summary_df_dict = {}\n",
    "\n",
    "for params in double_filtered_explorer_sheets_dict.keys():\n",
    "    G = params_graph_dict[params.split(\"_res\")[0]]\n",
    "    resolution = pd.to_numeric(params.split(\"res\")[1])\n",
    "    pc = PartitionCreator(G, df)\n",
    "    pc.create_partition_from_cmpvertexpartition(\n",
    "        n_iterations=iterations,\n",
    "        resolution_parameter=resolution,\n",
    "        verbose=False,\n",
    "        cluster_column_name=f\"cluster_{params}\",\n",
    "        centrality_column_name=f\"centrality_{params}\",\n",
    "    )\n",
    "    #############################\n",
    "    #############################\n",
    "    ce = CommunityExplorer(\n",
    "        df=pc.df,\n",
    "        cluster_column=f\"cluster_{params}\",\n",
    "        sort_column=f\"centrality_{params}\",\n",
    "        nr_tiles=15,\n",
    "    )\n",
    "    ce.create_full_explorer()\n",
    "    df_summary, cluster_titles_sheets_dict = ce.full_return()\n",
    "    # sort by Cluster\n",
    "\n",
    "    # save to excel\n",
    "    filepath = f\"../output/cluster-qualifications/cluster-explorer/FinalSelect/SingleSolExplorer_{params}.xlsx\"\n",
    "    NetworkAnalyzerUtils().clusters_excel_saver_with_hyperlinks(\n",
    "        filepath, df_summary, cluster_titles_sheets_dict\n",
    "    )\n",
    "    graph_summary_df_dict[params] = (df_summary, cluster_titles_sheets_dict)\n",
    "    print(f\"Params: {params}; Nr of clusters: {len(pc.partition.sizes())}\")\n",
    "    print(\"#\" * 50)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Explore based on Decision Criteria\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Decision Criteria:\n",
    "\n",
    "1. premature ejaculation and sexual dysfunction be distinct clusters\n",
    "2. Mixing of anxiety and panic disorder?\n",
    "3. Diabetic Mice VS Body Weight and Diabetes VS depression treatment in diabetics?\n",
    "4. Use alpha = 0.3 (look at alpha0.5_k10_res0.002); topics: 50, 133 -> very mixed words, little coherence.Not the case for alpha0.3_k10_res0.002 (here, sexual dys and premature ejac single topic though)\n",
    "5. Zimeldine (1 or two topics)\n",
    "6. Pregnancy related topics.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['alpha0.3_k15_res0.01', 'alpha0.5_k20_res0.01', 'alpha0.3_k10_res0.006', 'alpha0.3_k20_res0.01', 'alpha0.5_k15_res0.006', 'alpha0.3_k15_res0.006', 'alpha0.5_k20_res0.006', 'alpha0.3_k20_res0.006', 'alpha0.5_k20_res0.005', 'alpha0.3_k20_res0.005', 'alpha0.3_k10_res0.002'])"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "graph_summary_df_dict.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Params: alpha0.3_k15_res0.01\n",
      "Nr of clusters: 385\n",
      "##################################################\n",
      "Params: alpha0.5_k20_res0.01\n",
      "Nr of clusters: 369\n",
      "##################################################\n",
      "Params: alpha0.3_k10_res0.006\n",
      "Nr of clusters: 368\n",
      "##################################################\n",
      "Params: alpha0.3_k20_res0.01\n",
      "Nr of clusters: 298\n",
      "##################################################\n",
      "Params: alpha0.5_k15_res0.006\n",
      "Nr of clusters: 290\n",
      "##################################################\n",
      "Params: alpha0.3_k15_res0.006\n",
      "Nr of clusters: 246\n",
      "##################################################\n",
      "Params: alpha0.5_k20_res0.006\n",
      "Nr of clusters: 226\n",
      "##################################################\n",
      "Params: alpha0.3_k20_res0.006\n",
      "Nr of clusters: 192\n",
      "##################################################\n",
      "Params: alpha0.5_k20_res0.005\n",
      "Nr of clusters: 190\n",
      "##################################################\n",
      "Params: alpha0.3_k20_res0.005\n",
      "Nr of clusters: 162\n",
      "##################################################\n",
      "Params: alpha0.3_k10_res0.002\n",
      "Nr of clusters: 147\n",
      "##################################################\n"
     ]
    }
   ],
   "source": [
    "for params, suma in analysis_data_dict.items():\n",
    "    print(f\"Params: {params}\")\n",
    "    print(f\"Nr of clusters: {len(suma)}\")\n",
    "    print(\"#\" * 50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Words: PREMATURE EJACULATION\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 14;      Nr of Pubs in Cluster: 327\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine group mg ielt sertraline placebo fluoxetine sexual men ssris study efficacy treatment premature\n",
      "RANDOM TITLES\n",
      "Influence of tramadol on neurotransmitter systems of the rat brain\n",
      "Selective serotonin reuptake inhibitors for premature ejaculation: Review of erectile and ejaculatory side effects\n",
      "Current and Emerging Treatments for Premature Ejaculation\n",
      "Premature ejaculation\n",
      "Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.5_k20_res0.01;    Total Clusters: 369;     Cluster: 15;      Nr of Pubs in Cluster: 362\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine sexual mg group ielt fluoxetine sertraline placebo men ssris serotonin study efficacy\n",
      "RANDOM TITLES\n",
      "Treatment of premature ejaculation\n",
      "The efficacy and safety of on-demand tramadol and paroxetine use in treatment of life long premature ejaculation: A randomized double-blind placebo-controlled clinical trial\n",
      "Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: Analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil\n",
      "Extracellular serotonin in the lateral hypothalamic area is increased during the postejaculatory interval and impairs copulation in male rats\n",
      "Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: A double-bind, placebo controlled study\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 14;      Nr of Pubs in Cluster: 328\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine group mg ielt sertraline placebo fluoxetine sexual men ssris study efficacy serotonin\n",
      "RANDOM TITLES\n",
      "Influence of tramadol on neurotransmitter systems of the rat brain\n",
      "Comparison of the treatment efficacies of paroxetine, fluoxetine and dapoxetine in low socioeconomic status patients with lifelong premature ejaculation\n",
      "Selective Serotonin Reuptake Inhibitors Plus Phosphodiesterase-5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis\n",
      "Premature ejaculation\n",
      "Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k20_res0.01;    Total Clusters: 298;     Cluster: 20;      Nr of Pubs in Cluster: 335\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine group mg ielt sertraline sexual placebo men fluoxetine ssris study efficacy serotonin\n",
      "RANDOM TITLES\n",
      "Paroxetine in the treatment of premature ejaculation: A systematic review and meta-analysis\n",
      "Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: A systematic review and meta-analysis\n",
      "Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation\n",
      "Retraction: Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study (Journal of Clinical Psychopharmacology (2008) 28 (39-44) DOI: 10.1097/jcp.0b013e31816073a5)\n",
      "A systematic review and meta-analysis of randomized controlled trials of “on‑demand” use of tramadol vs “on‑demand” use of paroxetine in the management of patients with premature ejaculation\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.5_k15_res0.006;    Total Clusters: 290;     Cluster: 23;      Nr of Pubs in Cluster: 357\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine sexual mg group ielt sertraline placebo men fluoxetine ssris study serotonin efficacy\n",
      "RANDOM TITLES\n",
      "Is there a place for surgical treatment of premature ejaculation?\n",
      "Selective serotonin uptake inhibitor in the treatment of premature ejaculation\n",
      "Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation\n",
      "The efficacy of duloxetine in the treatment of premature ejaculation\n",
      "Comparison of the safety and efficacy of the on-demand use of sertraline, dapoxetine, and daily use of sertraline in the treatment of patients with lifelong premature ejaculation: A prospective randomised study\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k15_res0.006;    Total Clusters: 246;     Cluster: 29;      Nr of Pubs in Cluster: 337\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine group mg ielt sertraline sexual men placebo fluoxetine ssris study efficacy serotonin\n",
      "RANDOM TITLES\n",
      "Efficacy and safety of sertraline for the treatment of premature ejaculation: Systematic review and meta-analysis\n",
      "Dapoxetine hydrochloride: Treatment of premature ejaculation 5-HT reuptake inhibitor\n",
      "Sildenafil: a 4-year update in the treatment of 20 million erectile dysfunction patients.\n",
      "Retraction: Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study (Journal of Clinical Psychopharmacology (2008) 28 (39-44) DOI: 10.1097/jcp.0b013e31816073a5)\n",
      "A systematic review and meta-analysis of randomized controlled trials of “on‑demand” use of tramadol vs “on‑demand” use of paroxetine in the management of patients with premature ejaculation\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.5_k20_res0.006;    Total Clusters: 226;     Cluster: 28;      Nr of Pubs in Cluster: 370\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine sexual mg group ielt fluoxetine sertraline placebo men ssris serotonin study efficacy\n",
      "RANDOM TITLES\n",
      "Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation\n",
      "Serotonin impairs copulation and attenuates ejaculation-induced glutamate activity in the medial preoptic area\n",
      "Slimmer or Fertile? Pharmacological Mechanisms Involved in Reduced Sperm Quality and Fertility in Rats Exposed to the Anorexigen Sibutramine\n",
      "A bihormonal model of normal sexual stimulation; the etiology of premature ejaculation\n",
      "A network meta-analysis on comparative efficacy and tolerability of on-demand therapy for premature ejaculation\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k20_res0.006;    Total Clusters: 192;     Cluster: 39;      Nr of Pubs in Cluster: 339\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine group mg ielt sertraline sexual placebo men fluoxetine ssris study efficacy serotonin\n",
      "RANDOM TITLES\n",
      "Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials\n",
      "Premature Ejaculation Associated with Citalopram Withdrawal\n",
      "Antidepressants and ejaculation: A double-blind, randomized, fixed-dose study with mirtazapine and paroxetine\n",
      "Retraction: Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study (Journal of Clinical Psychopharmacology (2008) 28 (39-44) DOI: 10.1097/jcp.0b013e31816073a5)\n",
      "A systematic review and meta-analysis of randomized controlled trials of “on‑demand” use of tramadol vs “on‑demand” use of paroxetine in the management of patients with premature ejaculation\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.5_k20_res0.005;    Total Clusters: 190;     Cluster: 33;      Nr of Pubs in Cluster: 373\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine sexual mg group ielt fluoxetine sertraline men placebo ssris serotonin study efficacy\n",
      "RANDOM TITLES\n",
      "Pharmacogenetics and pharmacogenomics of sexual dysfunction: Current status, gaps and potential applications\n",
      "Rapid ejaculation: A review of nosology, prevalence and treatment\n",
      "Serum leptin and 5-hydroxytryptamine measurements for the diagnosis and treatment of premature ejaculation\n",
      "Comparison of fluoxetine with other selective serotonin reuptake inhibitors in the treatment of premature ejaculation: A systematic review and meta-analysis\n",
      "Pharmacotherapy for premature ejaculation\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k20_res0.005;    Total Clusters: 162;     Cluster: 44;      Nr of Pubs in Cluster: 339\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine group mg ielt sertraline sexual placebo men fluoxetine ssris study efficacy serotonin\n",
      "RANDOM TITLES\n",
      "Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials\n",
      "Premature Ejaculation Associated with Citalopram Withdrawal\n",
      "Antidepressants and ejaculation: A double-blind, randomized, fixed-dose study with mirtazapine and paroxetine\n",
      "Retraction: Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study (Journal of Clinical Psychopharmacology (2008) 28 (39-44) DOI: 10.1097/jcp.0b013e31816073a5)\n",
      "A systematic review and meta-analysis of randomized controlled trials of “on‑demand” use of tramadol vs “on‑demand” use of paroxetine in the management of patients with premature ejaculation\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k10_res0.002;    Total Clusters: 147;     Cluster: 43;      Nr of Pubs in Cluster: 352\n",
      "2016.0  ejaculation pe treatment premature premature ejaculation patients dapoxetine paroxetine group mg ielt sexual men placebo sertraline fluoxetine ssris study efficacy serotonin\n",
      "RANDOM TITLES\n",
      "Efficacy of selective serotonin reuptake inhibitor (SSRI) in patient with premature ejaculation\n",
      "Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects\n",
      "Possible association of the 5-HTTLPR serotonin transporter promoter gene polymorphism with premature ejaculation in a Turkish population\n",
      "New concepts in the diagnosis and treatment of premature ejaculation\n",
      "Influence of tramadol on neurotransmitter systems of the rat brain\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "No hits found for Parameters: \n",
      "set()\n",
      "\n"
     ]
    }
   ],
   "source": [
    "analysis_data_dict = graph_summary_df_dict\n",
    "print_n_random_titles = 5\n",
    "word1 = \"premature\"\n",
    "word2 = \"ejaculation\"\n",
    "print_word_string = True\n",
    "save_to_file = True\n",
    "file_name = f\"../output/cluster-qualifications/cluster-explorer/ParamsTestTxt/cluster_analysis_output_{word1}.txt\"\n",
    "\n",
    "NetworkAnalyzerUtils().cluster_coherence_analyzer_in_txt(\n",
    "    analysis_data_dict=analysis_data_dict,\n",
    "    print_n_random_titles=print_n_random_titles,\n",
    "    word1=word1,\n",
    "    word2=word2,\n",
    "    print_word_string=print_word_string,\n",
    "    save_to_file=save_to_file,\n",
    "    file_name=file_name,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Words: PREG \n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 0;      Nr of Pubs in Cluster: 568\n",
      "2017.0  pregnancy ssri women use risk exposure ssris serotonin depression antidepressants neonatal ci paroxetine antidepressant reuptake maternal birth exposed malformations associated\n",
      "RANDOM TITLES\n",
      "Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies\n",
      "Antidepressant use in pregnancy and the risk of cardiac defects\n",
      "Should we stop using tricyclic antidepressants in pregnancy?\n",
      "Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: A focus on methodological issues\n",
      "Antidepressant use during pregnancy: A critical systematic review of the literature\n",
      "Rate of Chiari i malformation in children of mothers with depression with and without prenatal SSRI exposure\n",
      "Maternal use of selective serotonin reuptake inhibitors and lengthening of the umbilical cord: Indirect evidence of increased foetal activity - A retrospective cohort study\n",
      "The safety of antidepressant drugs during pregnancy\n",
      "Breastfeeding among women exposed to antidepressants during pregnancy\n",
      "Determining the Severity of Neonatal Abstinence Syndrome Among Newborns Exposed to Selective Serotonin Reuptake Inhibitors and Serotonin and Norepinephrine Reuptake Inhibitors in Utero: A Protocol for a Systematic Review and Meta-Analysis\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 57;      Nr of Pubs in Cluster: 196\n",
      "2015.0  gad anxiety treatment patients disorder escitalopram anxiety disorder placebo generalized generalized anxiety generalized anxiety disorder paroxetine quetiapine efficacy pregabalin study xr week serotonin group\n",
      "RANDOM TITLES\n",
      "Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder\n",
      "Pharmacotherapy of generalized anxiety disorder\n",
      "Selecting pharmacotherapy for generalized anxiety disorder\n",
      "Remission of generalized anxiety disorder: A review of the paroxetine clinical trials database\n",
      "Treatment of generalized anxiety disorder\n",
      "Treatments for generalized anxiety disorder\n",
      "Escitalopram in the treatment of generalized anxiety disorder\n",
      "Duloxetine: A review of its use in the treatment of generalized anxiety disorder\n",
      "Efficacy and Safety of a Formulated Herbal Granula, Jiu Wei Zhen Xin, for Generalized Anxiety Disorder: A Meta-Analysis\n",
      "Determining the efficacy of electronic cognitive behavioral therapy for generalized anxiety disorder compared to pharmaceutical interventions: Protocol for a Quasi-Experimental Study\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 85;      Nr of Pubs in Cluster: 161\n",
      "2018.0  breast milk infant breast milk pregnancy sertraline fluoxetine infants concentrations paroxetine dose maternal serum breastfeeding drug feeding breast feeding plasma citalopram fluvoxamine\n",
      "RANDOM TITLES\n",
      "Excretion of Psychoactive Drugs into Breast Milk: Pharmacokinetic Principles and Recommendations\n",
      "Changes in antidepressant metabolism and dosing across pregnancy and early postpartum\n",
      "Placental Transfer of Antidepressant Medications: Implications for Postnatal Adaptation Syndrome\n",
      "Antidepressants in breast milk; comparative analysis of excretion ratios\n",
      "Pharmacokinetics of sertraline across pregnancy and postpartum\n",
      "Fluvoxamine in breast-milk and infant development [2]\n",
      "The use of antidepressants in pregnancy and lactation\n",
      "Sertraline and norsertraline levels in three breastfed infants\n",
      "Sertraline analysis in the plasma of breast-fed infants [7]\n",
      "Breastfeeding and sertraline: A 24-hour analysis\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 86;      Nr of Pubs in Cluster: 161\n",
      "2019.0  ssri exposure children autism pregnancy prenatal asd maternal risk use depression ssris serotonin ssri exposure exposed offspring study child associated reuptake\n",
      "RANDOM TITLES\n",
      "Affect expression in prenatally psychotropic exposed and nonexposed mother-infant dyads\n",
      "Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children\n",
      "Maternal Antidepressant Use during Pregnancy and the Risk of Attention-Deficit/Hyperactivity Disorder in Children: A Systematic Review of the Current Literature\n",
      "Functional dissection of prenatal drug effects on baby brain and behavioral development\n",
      "Association between antenatal exposure to selective serotonin reuptake inhibitors and autism: A need for further analysis\n",
      "Population-based association study and contrasting linkage disequilibrium pattern reveal genetic association of SLC6A4 with autism in the Indian population from West Bengal\n",
      "Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study\n",
      "Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications\n",
      "No association between prenatal exposure to psychotropics and intelligence at age five\n",
      "Autism and the serotonin transporter: The long and short of it\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 133;      Nr of Pubs in Cluster: 104\n",
      "2019.0  depression women postpartum treatment postpartum depression ppd pregnancy postnatal study postnatal depression antidepressants symptoms risk placebo antidepressant depressive anxiety sertraline weeks clinical\n",
      "RANDOM TITLES\n",
      "Risk factors for positive postpartum depression screen in women with private health insurance and access to care\n",
      "Expert consensus guidelines for the treatment of depression in women: A new treatment tool\n",
      "Factors Associated with Depressive and Anxiety Symptom Trajectories Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Individuals\n",
      "Pharmacological prophylaxis of postpartum exacerbation in depressive and anxiety symptoms: a retrospective study\n",
      "Comparing the Effectiveness of Internet Cognitive Behavioral Therapy and Drug Therapy for Treating Postpartum Depression and Children Weight Gain: A Randomized Clinical Trial\n",
      "Sequential serotonin and noradrenalin associated processes involved in postpartum blues\n",
      "Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression\n",
      "Promoting the well-being of mothers with multidisciplinary psychosocial interventions in the perinatal period\n",
      "Trajectories of Depressive and Anxiety Symptoms Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Women\n",
      "A Review of Treatments and Clinical Guidelines for Perinatal Depression\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 155;      Nr of Pubs in Cluster: 94\n",
      "2015.0  pulmonary ht hypertension fluoxetine serotonin pulmonary hypertension persistent pulmonary persistent pulmonary hypertension pah persistent risk pphn induced ssris ssri pregnancy arterial newborn pulmonary hypertension newborn pulmonary arterial\n",
      "RANDOM TITLES\n",
      "Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease\n",
      "Drugs induced pulmonary arterial hypertension\n",
      "Hemodynamic effects of fluoxetine in pulmonary arterial hypertension: an open label pilot study\n",
      "Monochorionic diamniotic twin pregnancy complicated by discordant premature closure of ductus arteriosus\n",
      "SSRI use in late pregnancy was associated with increased persistent pulmonary hypertension in newborns\n",
      "SSRI antidepressants: Persistent pulmonary hypertension in newborns (continued)\n",
      "Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension\n",
      "Sudden Onset of Severe Pulmonary Hypertension in a Preterm Infant: A Case Report on the Role of Maternal Use of Serotonin Re-Uptake Inhibitors During Pregnancy and Concurrent Risk Factors\n",
      "Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology\n",
      "The Use of Antidepressants and the Risk of Idiopathic Pulmonary Arterial Hypertension\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 179;      Nr of Pubs in Cluster: 84\n",
      "2013.0  fluoxetine serotonin serotonin reuptake reuptake selective serotonin reuptake selective serotonin selective serotonin reuptake inhibitors reuptake inhibitors inhibitors pregnancy exposure use risk exposure selective exposure selective serotonin reuptake inhibitors pregnancy inhibitors pregnancy use selective use selective serotonin\n",
      "RANDOM TITLES\n",
      "Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy [1]\n",
      "Parsing risk for the use of selective Serotonin Reuptake inhibitors in pregnancy\n",
      "Drug safety monitoring of 12 692 patients treated with fluoxetine\n",
      "Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects\n",
      "Selective serotonin reuptake inhibitors and risk for major congenital anomalies\n",
      "The safety of fluoxetine during pregnancy and lactation\n",
      "Selective serotonin reuptake inhibitors increase risk of preterm birth\n",
      "Outcome of children exposed in utero to fluoxetine: A critical review\n",
      "General health: Selective serotonin reuptake inhibitors and birth defects\n",
      "Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 198;      Nr of Pubs in Cluster: 78\n",
      "2016.75  allo 3α 5α brain fluoxetine allopregnanolone 3α 5α treatment depression levels thp kg rats mg neuroactive steroids ptsd mg kg antidepressant patients\n",
      "RANDOM TITLES\n",
      "The role of neurosteroids in the anxiolytic, antidepressive- and anticonvulsive effects of selective serotonin reuptake inhibitors\n",
      "Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine\n",
      "SSRIs and the female brain - Potential for utilizing steroid-stimulating properties to treat menstrual cycle-linked dysphorias\n",
      "In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis\n",
      "Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss\n",
      "Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids\n",
      "Neurosteroids reduce social isolation-induced behavioral deficits: A proposed link with neurosteroid-mediated upregulation of BDNF expression\n",
      "The effects of the estrus cycle and citalopram on anxiety-like behaviors and c-fos expression in rats\n",
      "The specificity of stress responses to different nocuous stimuli: Neurosteroids and depression\n",
      "Effects of fluoxetine, indomethacine and placebo on 3α, 5α tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.01;    Total Clusters: 385;     Cluster: 364;      Nr of Pubs in Cluster: 11\n",
      "2018.5  group cbt women depression control fluoxetine infertility infertile infertile women treatment control group intervention study vs mean scores anxiety pregnancy therapy significantly\n",
      "RANDOM TITLES\n",
      "The effect of the cognitive behavioral therapy and pharmacotherapy on infertility stress: A randomized controlled trial\n",
      "Psychiatric intervention improved pregnancy rates in infertile couples\n",
      "Comparison of midwifery consultation and fluoxetine on ivf outcomes in depressed infertile women: A clinical trial research study\n",
      "Comparison of pharmacological and nonpharmacological treatment strategies in promotion of infertility self-efficacy scale in infertile women: A randomized controlled trial\n",
      "Treatment of depression and anxiety in infertile women: Cognitive behavioral therapy versus fluoxetine\n",
      "The effect of antidepressant treatment on the HPA axis, changes in depression score and serum levels of TNF-α in depressed infertile women\n",
      "Is psychotherapy a reliable alternative to pharmacotherapy to promote the mental health of infertile women? A randomized clinical trial\n",
      "Depression, assisted reproductive technology/in vitro fertilization and selective serotonin reuptake inhibitors\n",
      "Antidepressants for polycystic ovary syndrome\n",
      "Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.3_k15_res0.01 **\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.5_k20_res0.01;    Total Clusters: 369;     Cluster: 0;      Nr of Pubs in Cluster: 667\n",
      "2017.0  pregnancy ssri risk use women exposure serotonin ssris reuptake serotonin reuptake selective selective serotonin depression inhibitors selective serotonin reuptake antidepressants reuptake inhibitors neonatal maternal serotonin reuptake inhibitors\n",
      "RANDOM TITLES\n",
      "In utero SSRI exposure and risk of clubfoot\n",
      "Treating Depression during Pregnancy: Are We Asking the Right Questions?\n",
      "Motherisk update: Counseling pregnant women treated with paroxetine. Concern about cardiac malformations\n",
      "Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension\n",
      "Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: A meta-analysis\n",
      "Use of antidepressants during pregnancy and neonatal outcomes: An umbrella review of meta-analyses of observational studies\n",
      "Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia\n",
      "The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants\n",
      "Incidence of major malformations in infants following antidepressant exposure in pregnancy: Results of a large prospective cohort study\n",
      "Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.01;    Total Clusters: 369;     Cluster: 72;      Nr of Pubs in Cluster: 188\n",
      "2015.0  gad anxiety treatment patients disorder placebo anxiety disorder escitalopram generalized generalized anxiety generalized anxiety disorder paroxetine quetiapine efficacy pregabalin study xr week serotonin group\n",
      "RANDOM TITLES\n",
      "Treatment of generalized anxiety disorder\n",
      "Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder\n",
      "Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): A new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder\n",
      "Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: A meta-analytic review\n",
      "Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder\n",
      "Development and evaluation of the Daily Assessment of Symptoms - Anxiety (DAS-A) scale to evaluate onset of symptom relief in patients with generalized anxiety disorder\n",
      "The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder\n",
      "An open, non-randomised comparison of escitalopram and duloxetine for the treatment of subjects with generalized anxiety disorder\n",
      "Selecting pharmacotherapy for generalized anxiety disorder\n",
      "Pharmacotherapy of generalized anxiety disorder\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.01;    Total Clusters: 369;     Cluster: 89;      Nr of Pubs in Cluster: 154\n",
      "2019.0  ssri exposure children pregnancy autism prenatal maternal asd risk use depression serotonin ssris ssri exposure offspring study exposed reuptake selective serotonin reuptake\n",
      "RANDOM TITLES\n",
      "Editorial: Optimizing neurodevelopmental outcomes in infants and children following prenatal SSRI exposure\n",
      "MAGDALENA: Study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero\n",
      "Intrauterine Exposure to Antidepressants or Maternal Depressive Symptoms and Offspring Brain White Matter Trajectories From Late Childhood to Adolescence\n",
      "Prenatal antidepressant exposure and sex differences in neonatal corpus callosum microstructure\n",
      "Prenatal exposure to selective serotonin reuptake inhibitors and risk of childhood overweight\n",
      "The association between antenatal exposure to selective serotonin reuptake inhibitors and autism: A systematic review and meta-analysis\n",
      "Nutritional implications of observed neurobehavioral disturbances and reduced gestation length in infants of mothers using selective serotonin reuptake inhibitors during pregnancy [5]\n",
      "Autism and the serotonin transporter: The long and short of it\n",
      "Association of maternal exposure to childhood abuse with elevated risk for autism in offspring\n",
      "Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.01;    Total Clusters: 369;     Cluster: 114;      Nr of Pubs in Cluster: 118\n",
      "2019.0  depression women postpartum treatment ppd postpartum depression pregnancy postnatal study group postnatal depression symptoms fluoxetine antidepressants risk placebo anxiety antidepressant depressive sertraline\n",
      "RANDOM TITLES\n",
      "Brexanolone Is the First Drug Specifically for Postpartum Depression\n",
      "Pharmacological prophylaxis of postpartum exacerbation in depressive and anxiety symptoms: a retrospective study\n",
      "Trajectory and Predictors of Depression and Anxiety Disorders in Mothers with the FMR1 Premutation\n",
      "Postpartum depression: What do pediatricians need to know?\n",
      "Case 24-2008: A 35-year-old woman with postpartum confusion, agitation, and delusions\n",
      "Factors Associated with Depressive and Anxiety Symptom Trajectories Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Individuals\n",
      "Development of neuroactive steroids for the treatment of postpartum depression\n",
      "Antepartum and postpartum depression: healthy mom, healthy baby.\n",
      "Postpartum depression – a review of current knowledge\n",
      "Implementation of Routine Postpartum Depression Screening and Care Initiation Across a Multispecialty Health Care Organization: An 18-Month Retrospective Analysis\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.01;    Total Clusters: 369;     Cluster: 176;      Nr of Pubs in Cluster: 79\n",
      "2016.5  3α allo 5α brain fluoxetine allopregnanolone 3α 5α cyp2d6 depression thp kg mg treatment levels mg kg ptsd neuroactive induced steroids antidepressant\n",
      "RANDOM TITLES\n",
      "Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder\n",
      "Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes\n",
      "Allopregnanolone in mood disorders: Mechanism and therapeutic development\n",
      "Biomarkers and treatments for mood disorders encompassing the neurosteroid and endocannabinoid systems\n",
      "GABA<inf>A</inf> receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment\n",
      "Actions of progesterone on depression-like behavior in a model of surgical menopause are mediated by GABA<inf>A</inf> receptors\n",
      "5α-reductase type i expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients\n",
      "Neuroactive steroids in affective disorders: Target for novel antidepressant or anxiolytic drugs?\n",
      "Social isolation as a promising animal model of PTSD comorbid suicide: neurosteroids and cannabinoids as possible treatment options\n",
      "Neurosteroids as neuromodulators in the treatment of anxiety disorders\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.01;    Total Clusters: 369;     Cluster: 248;      Nr of Pubs in Cluster: 48\n",
      "2020.25  ht serotonin transporter placental cells fetal human uptake binding 3h model pregnancy paroxetine maternal placenta μm fexofenadine fluoxetine serotonin transporter transport\n",
      "RANDOM TITLES\n",
      "Human amniocytes regulate serotonin levels by active uptake and express genes suggestive of a wider role in facilitating neurotransmitter regulation in the fetal environment\n",
      "Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model\n",
      "Xanthohumol impairs glucose uptake by a human first-trimester extravillous trophoblast cell line (HTR-8/SVneo cells) and impacts the process of placentation\n",
      "Development of serotonin transporter reuptake inhibition assays using JAR cells\n",
      "Possible prenatal impact of sertraline on human placental glutathione S-transferase-π\n",
      "Transporter-mediated release: A superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter\n",
      "Antidepressants and Antipsychotics in Human Pregnancy: Transfer Across the Placenta and Opportunities for Modeling Studies\n",
      "Pathway of Maternal Serotonin to the Human Embryo and Fetus\n",
      "Placental Changes in the serotonin transporter (Slc6a4) knockout mouse suggest a role for serotonin in controlling nutrient acquisition: Placental Changes in Slc6a4 (SERT) KO Mice\n",
      "The serotonin reuptake inhibitor fluoxetine induces human fetal membrane sterile inflammation through p38 MAPK activation\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.01;    Total Clusters: 369;     Cluster: 289;      Nr of Pubs in Cluster: 30\n",
      "2011.0  pregnancy fluoxetine use paroxetine exposure trimester outcome paroxetine use trimester exposure following fluoxetine use paroxetine use avoided use avoided use avoided pregnancy avoided avoided pregnancy safety outcome following outcome following trimester following trimester\n",
      "RANDOM TITLES\n",
      "A comparison of drug-induced cardiotoxicity in rat embryos cultured in human serum or protein free media\n",
      "Comment: Paroxetine use during pregnancy: Is it safe? [7]\n",
      "Should paroxetine be used to treat depression during pregnancy?\n",
      "Fetal exposure to pimozide: A case report\n",
      "Erratum to The fetal safety of fluoxetine: A systematic review and meta-analysis [J Obstet Gynaecol Can (2013) 35(4), 362-369]\n",
      "Fluoxetine and pregnancy a safe mix?\n",
      "Successful use of risperidone, trihexyphenidyl, and paroxetine in pregnancy\n",
      "Paroxetine use should be avoided during pregnancy\n",
      "Gastroschisis and cumulative stressor exposures\n",
      "RE: Paroxetine use should be avoided during pregnancy\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.01;    Total Clusters: 369;     Cluster: 319;      Nr of Pubs in Cluster: 19\n",
      "2019.5  nas opioid drugs methadone use neonatal syndrome infants group drug infant exposure maternal women prescription abuse pregnancy abstinence neonatal abstinence study\n",
      "RANDOM TITLES\n",
      "Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone\n",
      "Birth with Synthetic Oxytocin and Risk of Childhood Emotional Disorders: A Danish Population-based Study\n",
      "Male Sex Associated With Increased Risk of Neonatal Abstinence Syndrome\n",
      "Prescription opioid epidemic and infant outcomes\n",
      "Diagnosis of neonatal abstinence syndrome: Substance use during pregnancy\n",
      "Sudden infant death syndrome, child sexual abuse, and child development\n",
      "Determining the Severity of Neonatal Abstinence Syndrome Among Newborns Exposed to Selective Serotonin Reuptake Inhibitors and Serotonin and Norepinephrine Reuptake Inhibitors in Utero: A Protocol for a Systematic Review and Meta-Analysis\n",
      "Psychiatric medication use among pregnant and breastfeeding mothers who used cannabis for mental health concerns: A cross-sectional survey study\n",
      "Infant autonomic functioning and neonatal abstinence syndrome\n",
      "Prevalence of xenobiotic substances in first-trimester blood samples from Danish pregnant women: A cross-sectional study\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.5_k20_res0.01 **\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 0;      Nr of Pubs in Cluster: 607\n",
      "2017.0  pregnancy ssri women use risk exposure ssris depression serotonin antidepressants reuptake ci maternal neonatal antidepressant exposed birth serotonin reuptake selective inhibitors\n",
      "RANDOM TITLES\n",
      "Why the maternal medication list matters: Neonatal toxicity from combined serotonergic exposures\n",
      "The safety of antidepressant drugs during pregnancy\n",
      "Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: A population-based study in six European regions\n",
      "To evaluate the effects of antidepressant drugs on pregnancy outcomes in a university hospital of Turkey\n",
      "Maternal exposure to SSRIs or SNRIs and the risk of congenital abnormalities in offspring: A systematic review and meta-Analysis\n",
      "Should we stop using tricyclic antidepressants in pregnancy?\n",
      "Exposure to selective noradrenalin reuptake inhibitors during the first trimester of pregnancy and risk of congenital malformations: A meta-analysis of cohort studies\n",
      "Neonatal paroxetine withdrawal syndrome\n",
      "Transient neonatal jitteriness due to maternal use of sertraline (Zoloft®)\n",
      "Fetal and Neonatal Effects of Maternal Drug Treatment for Depression\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 61;      Nr of Pubs in Cluster: 198\n",
      "2015.0  gad anxiety treatment patients disorder anxiety disorder escitalopram placebo generalized generalized anxiety generalized anxiety disorder paroxetine quetiapine efficacy pregabalin study serotonin symptoms week group\n",
      "RANDOM TITLES\n",
      "Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada\n",
      "Pharmacotherapy of generalized anxiety disorder\n",
      "Recent developments in the research on generalized anxiety disorder\n",
      "Generalised anxiety disorder\n",
      "Treatment of generalized anxiety disorder\n",
      "Evaluation of an interactive training program focusing on the pharmacotherapy of generalized anxiety disorder\n",
      "Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.\n",
      "Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders\n",
      "Observational multicenter study of efficacy of paroxetine film-coated tablet in the treatment of anxiety disorder\n",
      "Efficacy of a multispecies probiotic as adjunctive therapy in generalized anxiety disorder: a double blind, randomized, placebo-controlled trial\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 84;      Nr of Pubs in Cluster: 160\n",
      "2018.0  breast milk infant breast milk pregnancy sertraline fluoxetine infants concentrations paroxetine dose maternal serum breastfeeding feeding breast feeding drug citalopram plasma women\n",
      "RANDOM TITLES\n",
      "Excretion of Psychoactive Drugs into Breast Milk: Pharmacokinetic Principles and Recommendations\n",
      "Changes in antidepressant metabolism and dosing across pregnancy and early postpartum\n",
      "Sertraline and breastfeeding: review and meta-analysis\n",
      "Are psychotropic drugs safe to use during lactation?\n",
      "Pharmacokinetics of sertraline across pregnancy and postpartum\n",
      "Fluvoxamine in breast-milk and infant development [2]\n",
      "A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate\n",
      "Sertraline and norsertraline levels in three breastfed infants\n",
      "Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk\n",
      "Breastfeeding and sertraline: A 24-hour analysis\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 88;      Nr of Pubs in Cluster: 151\n",
      "2019.0  ssri exposure autism children pregnancy asd prenatal risk maternal use depression serotonin ssris exposed ssri exposure offspring associated disorder reuptake ci\n",
      "RANDOM TITLES\n",
      "Effect of Selective Serotonin Reuptake Inhibitor Use in Pregnancy on Emotional Health of Children\n",
      "Association of selective serotonin reuptake inhibitor exposure during pregnancy with speech, scholastic, and motor disorders in offspring\n",
      "Parental broader autism subphenotypes in asd affected families: Relationship to gender, child's symptoms, SSRI treatment, and platelet serotonin\n",
      "5-HTTLPR polymorphism: Analysis in South African autistic individuals\n",
      "Depression and SSRI use in pregnancy associated with traits of autism in children\n",
      "Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years — Results from the prospective cohort SMOK study\n",
      "Lack of evidence for association between the serotonin transporter gene (SLC6A4) polymorphisms and autism in the Chinese trios\n",
      "DNA methylation in cord blood in association with prenatal depressive symptoms\n",
      "Use of selective serotonin reuptake inhibitors during pregnancy and risk for autism\n",
      "No association between prenatal exposure to psychotropics and intelligence at age five\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 144;      Nr of Pubs in Cluster: 100\n",
      "2019.0  3α 5α allo rats brain fluoxetine allopregnanolone depression 3α 5α like treatment kg levels ppd mg postpartum mg kg thp antidepressant neuroactive\n",
      "RANDOM TITLES\n",
      "Effects of paroxetine treatment and its withdrawal on neurosteroidogenesis\n",
      "Brain neurosteroids in gender-related aggression induced by social isolation\n",
      "Effect of the sEH inhibitor AUDA on arachidonic acid metabolism and NF-κB signaling of rats with postpartum depression-like behavior\n",
      "Antidepressant-like effects of omega-3 fatty acids in postpartum model of depression in rats\n",
      "Development of neuroactive steroids for the treatment of postpartum depression\n",
      "Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women\n",
      "The role of neurosteroids in the anxiolytic, antidepressive- and anticonvulsive effects of selective serotonin reuptake inhibitors\n",
      "Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes\n",
      "Paeoniflorin exhibits antidepressant activity in rats with postpartum depression via the TSPO and BDNF-mTOR pathways\n",
      "Reproductive experience alters the effects of diazepam and fluoxetine on anxiety-like behaviour, fear extinction, and corticosterone levels in female rats\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 148;      Nr of Pubs in Cluster: 97\n",
      "2019.0  depression postpartum women treatment postpartum depression ppd postnatal study postnatal depression pregnancy symptoms placebo risk antidepressant antidepressants anxiety depressive sertraline weeks trial\n",
      "RANDOM TITLES\n",
      "Expert consensus guidelines for the treatment of depression in women: A new treatment tool\n",
      "Depression, depressive symptoms and treatments in women who have recently given birth: UK cohort study\n",
      "A Review of Treatments and Clinical Guidelines for Perinatal Depression\n",
      "Risk factors for hospitalizations associated with depression among women during the years around a birth: A retrospective cohort study\n",
      "Efficacy of transcranial magnetic stimulation and fluoxetine in the treatment of postpartum depression: A protocol for systematic review and meta-analysis\n",
      "Acupuncture versus antidepressants in the management of postpartum depression: A systematic review\n",
      "Psychological interventions for postnatal depression: Cluster randomised trial and economic evaluation. The PoNDER trial\n",
      "Factors Associated with Depressive and Anxiety Symptom Trajectories Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Individuals\n",
      "A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression\n",
      "Performance evaluation of propensity score methods for estimating average treatment effects with multi-level treatments<sup>*</sup>\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 194;      Nr of Pubs in Cluster: 73\n",
      "2013.0  reuptake serotonin reuptake selective serotonin reuptake selective serotonin selective serotonin reuptake inhibitors serotonin reuptake inhibitors pregnancy inhibitors fluoxetine exposure use risk inhibitors pregnancy reuptake inhibitors pregnancy use selective use selective serotonin exposure selective serotonin exposure selective\n",
      "RANDOM TITLES\n",
      "Selective serotonin reuptake inhibitors increase risk of preterm birth\n",
      "Erratum to The fetal safety of fluoxetine: A systematic review and meta-analysis [J Obstet Gynaecol Can (2013) 35(4), 362-369]\n",
      "General health: Selective serotonin reuptake inhibitors and birth defects\n",
      "Interaction of maternal smoking and other in-pregnancy exposures: Analytic considerations\n",
      "The safety of fluoxetine during pregnancy and lactation\n",
      "Fluoxetine and pregnancy a safe mix?\n",
      "Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review\n",
      "Selective Serotonin Reuptake Inhibitor Use during Pregancy Associated with Premature Delivery\n",
      "Antenatal exposure to selective serotonin reuptake inhibitors and duration of gestation\n",
      "Neonatal signs after in utero exposure to selective serotonin reuptake inhibitors [4] (multiple letters)\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 305;      Nr of Pubs in Cluster: 29\n",
      "2014.0  paroxetine pregnancy use paroxetine use malformations exposure risk defects congenital cardiac associated use avoided avoided paroxetine use avoided avoided pregnancy use avoided pregnancy paroxetine pregnancy use pregnancy paroxetine use pregnancy congenital malformations\n",
      "RANDOM TITLES\n",
      "Paroxetine exposure during pregnancy and the risk of cardiac malformations: What is the evidence?\n",
      "Different malformations with SSRIs: Deformities were more common with paroxetine and fluoxetine\n",
      "Paroxetine use during pregnancy and the risk of cardiac defects\n",
      "Paroxetine is associated with malformation during pregnancy\n",
      "Treacher Collins syndrome with multiple congenital heart defects after paroxetine exposure: Case report\n",
      "RE: Paroxetine use should be avoided during pregnancy\n",
      "Low-dose paroxetine exposure causes lifetime declines in male mouse body weight, reproduction and competitive ability as measured by the novel organismal performance assay\n",
      "Comment: Paroxetine use during pregnancy: Is it safe? [7]\n",
      "Paroxetine exposure skews litter sex ratios in mice suggesting a Trivers-Willard process\n",
      "Paroxetine use during pregnancy associated with neonatal intracerebral bleeding\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 347;      Nr of Pubs in Cluster: 16\n",
      "2019.0  nas opioid drugs use methadone neonatal syndrome group drug exposure infant maternal women abuse prescription associated pregnancy deliveries risk study\n",
      "RANDOM TITLES\n",
      "Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone\n",
      "Psychiatric medication use among pregnant and breastfeeding mothers who used cannabis for mental health concerns: A cross-sectional survey study\n",
      "Detection of drugs in paired maternal and umbilical cord blood samples\n",
      "Diagnosis of neonatal abstinence syndrome: Substance use during pregnancy\n",
      "Relationship between methadone, selective serotonin reuptake inhibitors, and neonatal abstinence syndrome\n",
      "Sudden infant death syndrome, child sexual abuse, and child development\n",
      "Head circumference in infants with nonopiate-induced neonatal abstinence syndrome\n",
      "Prescription opioid epidemic and infant outcomes\n",
      "Effect of maternal substance abuse on the fetus, neonate, and child\n",
      "Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.006;    Total Clusters: 368;     Cluster: 359;      Nr of Pubs in Cluster: 9\n",
      "2020.0  cbt group fluoxetine women depression infertility control treatment infertile infertile women intervention patients vs therapy pregnancy significantly mean anxiety control group scores\n",
      "RANDOM TITLES\n",
      "Comparison of midwifery consultation and fluoxetine on ivf outcomes in depressed infertile women: A clinical trial research study\n",
      "Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine-treatment: 16-week open label study\n",
      "Is psychotherapy a reliable alternative to pharmacotherapy to promote the mental health of infertile women? A randomized clinical trial\n",
      "Pharmacotherapy or Psychotherapy? Selective Treatment Depression in The Infertile Women with Recurrent Pregnancy Loss: A Triple-Arm Randomized Controlled Trial\n",
      "Comparison of pharmacological and nonpharmacological treatment strategies in promotion of infertility self-efficacy scale in infertile women: A randomized controlled trial\n",
      "Psychiatric intervention improved pregnancy rates in infertile couples\n",
      "The effect of the cognitive behavioral therapy and pharmacotherapy on infertility stress: A randomized controlled trial\n",
      "Treatment of depression and anxiety in infertile women: Cognitive behavioral therapy versus fluoxetine\n",
      "The effect of antidepressant treatment on the HPA axis, changes in depression score and serum levels of TNF-α in depressed infertile women\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.3_k10_res0.006 **\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k20_res0.01;    Total Clusters: 298;     Cluster: 0;      Nr of Pubs in Cluster: 673\n",
      "2017.0  pregnancy use risk ssri women exposure serotonin ssris reuptake serotonin reuptake selective selective serotonin inhibitors selective serotonin reuptake reuptake inhibitors neonatal antidepressants depression serotonin reuptake inhibitors ci\n",
      "RANDOM TITLES\n",
      "SSRI use during pregnancy and risk for postpartum haemorrhage: a national register-based cohort study in Sweden\n",
      "Choosing an SSRI in pregnancy: Clinical context versus statistical significance\n",
      "Neurobehavioral risks of SSRIs in pregnancy: Comparing human and animal data\n",
      "First-trimester use of paroxetine and congenital heart defects: A population-based case-control study\n",
      "Delivery outcome in relation to maternal use of some recently introduced antidepressants\n",
      "Serotonin syndrome in a breast-fed neonate\n",
      "Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn\n",
      "Antenatal maternal antidepressants drugs affect S100B concentrations in fetal-maternal biological fluids\n",
      "Neonatal paroxetine withdrawal syndrome\n",
      "Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: Implications for fetal programming\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k20_res0.01;    Total Clusters: 298;     Cluster: 76;      Nr of Pubs in Cluster: 197\n",
      "2015.0  gad anxiety treatment patients disorder escitalopram anxiety disorder placebo generalized generalized anxiety generalized anxiety disorder paroxetine quetiapine efficacy pregabalin study xr week serotonin group\n",
      "RANDOM TITLES\n",
      "Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint\n",
      "Pharmacotherapy of generalized anxiety disorder\n",
      "Low-dose tiagabine effectiveness in anxiety disorders\n",
      "Remission of generalized anxiety disorder: A review of the paroxetine clinical trials database\n",
      "Treatment of generalized anxiety disorder\n",
      "Remission rates in patients with anxiety disorders treated with paroxetine\n",
      "Escitalopram for the treatment of GAD: Efficacy across different subgroups and outcomes\n",
      "Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: An open label study\n",
      "Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials\n",
      "Determining the efficacy of electronic cognitive behavioral therapy for generalized anxiety disorder compared to pharmaceutical interventions: Protocol for a Quasi-Experimental Study\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k20_res0.01;    Total Clusters: 298;     Cluster: 94;      Nr of Pubs in Cluster: 160\n",
      "2018.0  breast milk infant breast milk fluoxetine sertraline pregnancy concentrations infants paroxetine dose maternal serum breastfeeding drug feeding breast feeding plasma fluvoxamine citalopram\n",
      "RANDOM TITLES\n",
      "Excretion of Psychoactive Drugs into Breast Milk: Pharmacokinetic Principles and Recommendations\n",
      "Antidepressant medication use during breastfeeding\n",
      "Transdermal Estradiol Treatment for Postpartum Depression: A Pilot, Randomized Trial\n",
      "Are psychotropic drugs safe to use during lactation?\n",
      "Changes in antidepressant metabolism and dosing across pregnancy and early postpartum\n",
      "Fluvoxamine in breast-milk and infant development [2]\n",
      "Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations\n",
      "Sertraline and norsertraline levels in three breastfed infants\n",
      "Benefits and risks to mother and infant of drug treatment for postnatal depression\n",
      "Breastfeeding and sertraline: A 24-hour analysis\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k20_res0.01;    Total Clusters: 298;     Cluster: 96;      Nr of Pubs in Cluster: 158\n",
      "2019.0  ssri exposure children autism pregnancy prenatal maternal asd risk use depression serotonin ssris ssri exposure offspring exposed reuptake study associated selective\n",
      "RANDOM TITLES\n",
      "Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy\n",
      "Association between antenatal exposure to selective serotonin reuptake inhibitors and autism: A need for further analysis\n",
      "Thalamocortical functional connectivity and behavioral disruptions in neonates with prenatal cocaine exposure\n",
      "Effects of maternal depression and prenatal SSRI exposure on executive functions and susceptibility to household chaos in 6-year-old children: Prospective cohort study\n",
      "Antidepressant use during pregnancy and childhood autism spectrum disorders\n",
      "Use of selective serotonin reuptake inhibitors during pregnancy and risk for autism\n",
      "Selective Serotonin Reuptake Inhibitor Use Associated with Decreased Growth in Children\n",
      "Nutritional implications of observed neurobehavioral disturbances and reduced gestation length in infants of mothers using selective serotonin reuptake inhibitors during pregnancy [5]\n",
      "Serotonin Hypothesis of Autism: Implications for Selective Serotonin Reuptake Inhibitor Use during Pregnancy\n",
      "Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k20_res0.01;    Total Clusters: 298;     Cluster: 125;      Nr of Pubs in Cluster: 120\n",
      "2019.0  depression women postpartum treatment postpartum depression pregnancy ppd postnatal study group antidepressants postnatal depression symptoms risk fluoxetine antidepressant anxiety placebo sertraline depressive\n",
      "RANDOM TITLES\n",
      "Psychosomatic disorders in pregnancy\n",
      "Depression, depressive symptoms and treatments in women who have recently given birth: UK cohort study\n",
      "Advances in the pharmacological management of obsessive-compulsive disorder in the postpartum period\n",
      "Fluvoxamine for postpartum depression [7]\n",
      "Fluoxetine vs counselling for postnatal depression\n",
      "Factors Associated with Depressive and Anxiety Symptom Trajectories Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Individuals\n",
      "Mental disorders and risk factors among pregnant women with depressive symptoms in Sweden—A case-control study\n",
      "A woman with major depression with psychotic features requesting a termination of pregnancy\n",
      "Contraceptives as possible risk factors for postpartum depression: A retrospective study of the food and drug administration adverse event reporting system, 2004–2015\n",
      "Commentary on a Cochrane Review of Antidepressants for Postpartum Depression\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k20_res0.01;    Total Clusters: 298;     Cluster: 190;      Nr of Pubs in Cluster: 71\n",
      "2017.0  3α allo 5α brain fluoxetine 3α 5α allopregnanolone treatment depression thp kg levels mg mg kg neuroactive steroids ptsd patients mice content\n",
      "RANDOM TITLES\n",
      "Anxiolytic and Anti-depressive Like Effects of Translocator Protein (18 kDa) Ligand YL-IPA08 in a Rat Model of Postpartum Depression\n",
      "Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder\n",
      "Studies on neurosteroids XXVI. Fluoxetine-evoked changes in rat brain and serum levels of neuroactive androgen, 5α-androstane-3α,17β-diol\n",
      "In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine\n",
      "Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes\n",
      "Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain\n",
      "Allopregnanolone in mood disorders: Mechanism and therapeutic development\n",
      "Brain neurosteroid changes after paroxetine administration in mice\n",
      "Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: Implications for therapeutic actions\n",
      "Brain neurosteroids in gender-related aggression induced by social isolation\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.3_k20_res0.01 **\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.5_k15_res0.006;    Total Clusters: 290;     Cluster: 0;      Nr of Pubs in Cluster: 745\n",
      "2017.0  pregnancy use risk ssri women exposure serotonin ssris reuptake serotonin reuptake depression selective selective serotonin inhibitors selective serotonin reuptake fluoxetine reuptake inhibitors antidepressants maternal neonatal\n",
      "RANDOM TITLES\n",
      "Depression in Pregnancy\n",
      "Paroxetine and congenital malformations: Meta-Analysis and consideration of potential confounding factors\n",
      "Stereoselective pharmacokinetics of fluoxetine and norfluoxetine enantiomers in pregnant sheep\n",
      "Suspected congenital sertraline dependence [4]\n",
      "Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood\n",
      "Safety of selective serotonin reuptake inhibitors in pregnancy\n",
      "SSRI use during pregnancy and risk of stillbirth and neonatal mortality\n",
      "Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands\n",
      "Effects of fluoxetine on human embryo development\n",
      "Tandem mass spectrometry determined maternal cortisone to cortisol ratio and psychiatric morbidity during pregnancy-interaction with birth weight\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k15_res0.006;    Total Clusters: 290;     Cluster: 5;      Nr of Pubs in Cluster: 541\n",
      "2019.0  exposure fluoxetine ssri maternal stress offspring prenatal flx serotonin rats effects treatment pregnancy depression behavior ssris children brain ht development\n",
      "RANDOM TITLES\n",
      "The effects of maternal SSRI exposure on the serotonin system, prefrontal protein expression and behavioral development in male and female offspring rats\n",
      "Postnatal exposure to fluoxetine led to cognitive-emotional alterations and decreased parvalbumin positive neurons in the hippocampus of juvenile Wistar rats\n",
      "Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: Need for Further Investigation\n",
      "Sex-dependent effects of maternal corticosterone and SSRI treatment on hippocampal neurogenesis across development\n",
      "Maternal exercise increases but concurrent maternal fluoxetine prevents the increase in hippocampal neurogenesis of adult offspring\n",
      "Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: A population-based cohort study\n",
      "Dr. Lupattelli et al. Reply\n",
      "Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life\n",
      "Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study\n",
      "Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k15_res0.006;    Total Clusters: 290;     Cluster: 168;      Nr of Pubs in Cluster: 70\n",
      "2014.0  3α allo 5α brain fluoxetine 3α 5α allopregnanolone thp depression treatment kg mg mg kg levels steroids ptsd neuroactive antidepressant patients concentrations\n",
      "RANDOM TITLES\n",
      "Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine\n",
      "Antidepressant-like effect of fluoxetine may depend on translocator protein activity and pretest session duration in forced swimming test in mice\n",
      "Neurosteroids in depression: A review\n",
      "Neurosteroids as neuromodulators in the treatment of anxiety disorders\n",
      "Cytochrome P450 2D Catalyze Steroid 21-Hydroxylation in the Brain\n",
      "SSRIs and the female brain - Potential for utilizing steroid-stimulating properties to treat menstrual cycle-linked dysphorias\n",
      "Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes\n",
      "Rapid anti-PTSD-like activity of the TSPO agonist YL-IPA08: Emphasis on brain GABA, neurosteroids and HPA axis function\n",
      "Effects of estrogen and progesterone on neuroactive steroids and cytokines in patients with suicidality\n",
      "Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k15_res0.006;    Total Clusters: 290;     Cluster: 255;      Nr of Pubs in Cluster: 21\n",
      "2020.0  nas opioid placental use drugs methadone neonatal syndrome maternal infants group drug infant exposure women prescription pregnancy abuse study associated\n",
      "RANDOM TITLES\n",
      "Head circumference in infants with nonopiate-induced neonatal abstinence syndrome\n",
      "Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone\n",
      "Placental Passage of Humulone and Protopine in an Ex Vivo Human Perfusion System <sup>#</sup>\n",
      "Male Sex Associated With Increased Risk of Neonatal Abstinence Syndrome\n",
      "Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome\n",
      "Psychiatric medication use among pregnant and breastfeeding mothers who used cannabis for mental health concerns: A cross-sectional survey study\n",
      "Prescription opioid epidemic and infant outcomes\n",
      "Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drugs in plasma\n",
      "Maternal stress and placental function; Ex vivo placental perfusion studying cortisol, cortisone, tryptophan and serotonin\n",
      "Diagnosis of neonatal abstinence syndrome: Substance use during pregnancy\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.5_k15_res0.006 **\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k15_res0.006;    Total Clusters: 246;     Cluster: 0;      Nr of Pubs in Cluster: 726\n",
      "2017.0  pregnancy use risk ssri women exposure serotonin ssris reuptake depression serotonin reuptake selective inhibitors selective serotonin selective serotonin reuptake reuptake inhibitors antidepressants neonatal maternal fluoxetine\n",
      "RANDOM TITLES\n",
      "Use of SSRI and SNRI antidepressants during pregnancy: A population-based study from Denmark, Iceland, Norway and Sweden\n",
      "Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: Protocol for a retrospective population-based cohort study using linked administrative data\n",
      "Association of citalopram with congenital anomalies: A meta-analysis\n",
      "Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis\n",
      "SSRI antidepressants in utero: pulmonary hypertension\n",
      "Neonate Characteristics after Maternal Use of Antidepressants in Late Pregnancy\n",
      "Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes (Archives of Pediatrics and Adolescent Medicine (2009) 163, 10, (949-954))\n",
      "Breastfeeding among women exposed to antidepressants during pregnancy\n",
      "In vitro and in vivo reproduction toxicology of 12 monoaminergic reuptake inhibitors: Possible mechanisms of infrequent cardiovascular anomalies\n",
      "Antidepressant use during pregnancy: A critical systematic review of the literature\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.006;    Total Clusters: 246;     Cluster: 80;      Nr of Pubs in Cluster: 199\n",
      "2015.0  gad anxiety treatment patients disorder anxiety disorder placebo escitalopram generalized generalized anxiety generalized anxiety disorder paroxetine quetiapine efficacy pregabalin study group xr week serotonin\n",
      "RANDOM TITLES\n",
      "Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint\n",
      "Pharmacotherapy of generalized anxiety disorder\n",
      "Selecting pharmacotherapy for generalized anxiety disorder\n",
      "Remission of generalized anxiety disorder: A review of the paroxetine clinical trials database\n",
      "Treatment of generalized anxiety disorder\n",
      "Treatments for generalized anxiety disorder\n",
      "Escitalopram in the treatment of generalized anxiety disorder\n",
      "Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: An open label study\n",
      "Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions\n",
      "Determining the efficacy of electronic cognitive behavioral therapy for generalized anxiety disorder compared to pharmaceutical interventions: Protocol for a Quasi-Experimental Study\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.006;    Total Clusters: 246;     Cluster: 99;      Nr of Pubs in Cluster: 164\n",
      "2018.0  breast milk infant breast milk sertraline pregnancy fluoxetine infants concentrations paroxetine dose maternal serum breastfeeding drug feeding breast feeding women plasma fluvoxamine\n",
      "RANDOM TITLES\n",
      "Sertraline analysis in the plasma of breast-fed infants [7]\n",
      "Antidepressants and Antipsychotics in Human Pregnancy: Transfer Across the Placenta and Opportunities for Modeling Studies\n",
      "Sertraline and norsertraline levels in three breastfed infants\n",
      "Antidepressant drugs and breastfeeding: A review of the literature\n",
      "Pregnancy exposure to citalopram – Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood\n",
      "Excretion of Psychoactive Drugs into Breast Milk: Pharmacokinetic Principles and Recommendations\n",
      "Distribution and excretion of fluoxetine and norfluoxetine in human milk\n",
      "Safety of psychotropic medications in breastfeeding\n",
      "An in vivo evaluation of the ontogeny of stereoselective fluoxetine metabolism and disposition in lambs from birth to one year of age\n",
      "Fluvoxamine in breast-milk and infant development [2]\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.006;    Total Clusters: 246;     Cluster: 125;      Nr of Pubs in Cluster: 109\n",
      "2018.0  autism pregnancy children asd risk exposure ssri use serotonin prenatal ssris adhd maternal offspring association ci autism spectrum spectrum disorder reuptake\n",
      "RANDOM TITLES\n",
      "Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders\n",
      "Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: A population-based cohort study\n",
      "Association Between Maternal Use of SSRI Medications and Autism in Their Children\n",
      "Prenatal Selective Serotonin Reuptake Inhibitor Exposure and Child Neurodevelopment: The Importance of Maternal Mental Illness\n",
      "In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder\n",
      "Prenatal Antidepressant Exposures and Autism Spectrum Disorder or Traits: A Retrospective, Multi-Cohort Study\n",
      "Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study\n",
      "Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age\n",
      "SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: A study from an Indian population\n",
      "Commentary: Studies of prenatal antidepressant exposures: what can you recommend? A reflection on Sujan et al. (2019)\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.006;    Total Clusters: 246;     Cluster: 144;      Nr of Pubs in Cluster: 91\n",
      "2018.5  3α allo 5α fluoxetine brain rats depression allopregnanolone treatment 3α 5α like ppd kg postpartum levels mg mg kg thp neuroactive antidepressant\n",
      "RANDOM TITLES\n",
      "The specificity of stress responses to different nocuous stimuli: Neurosteroids and depression\n",
      "The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins\n",
      "Physiological markers of rapid antidepressant effects of allopregnanolone\n",
      "Review of allopregnanolone agonist therapy for the treatment of depressive disorders\n",
      "Antidepressant-like effects of omega-3 fatty acids in postpartum model of depression in rats\n",
      "Social isolation as a promising animal model of PTSD comorbid suicide: neurosteroids and cannabinoids as possible treatment options\n",
      "Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: Implications for therapeutic actions\n",
      "Effect of the sEH inhibitor AUDA on arachidonic acid metabolism and NF-κB signaling of rats with postpartum depression-like behavior\n",
      "Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss\n",
      "Biomarkers and treatments for mood disorders encompassing the neurosteroid and endocannabinoid systems\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k15_res0.006;    Total Clusters: 246;     Cluster: 146;      Nr of Pubs in Cluster: 91\n",
      "2019.0  depression women postpartum treatment postpartum depression ppd postnatal postnatal depression study placebo symptoms pregnancy anxiety antidepressants risk antidepressant sertraline trial weeks fluoxetine\n",
      "RANDOM TITLES\n",
      "Expert consensus guidelines for the treatment of depression in women: A new treatment tool\n",
      "Advances in the pharmacological management of obsessive-compulsive disorder in the postpartum period\n",
      "Trajectories of Depressive and Anxiety Symptoms Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Women\n",
      "Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Meta-Analysis of Pharmacotherapy\n",
      "Identification and management of peripartum depression\n",
      "Interventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement\n",
      "Does maternal role functioning improve with antidepressant treatment in women with postpartum depression?\n",
      "Factors Associated with Depressive and Anxiety Symptom Trajectories Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Individuals\n",
      "A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression\n",
      "Comparing the Effectiveness of Internet Cognitive Behavioral Therapy and Drug Therapy for Treating Postpartum Depression and Children Weight Gain: A Randomized Clinical Trial\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.3_k15_res0.006 **\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.5_k20_res0.006;    Total Clusters: 226;     Cluster: 0;      Nr of Pubs in Cluster: 902\n",
      "2018.0  pregnancy ssri exposure use risk women serotonin ssris depression reuptake maternal serotonin reuptake selective selective serotonin selective serotonin reuptake inhibitors antidepressants reuptake inhibitors fluoxetine ci\n",
      "RANDOM TITLES\n",
      "SSRI use in late pregnancy was associated with increased persistent pulmonary hypertension in newborns\n",
      "Are the new SSRIs safe for pregnant women?\n",
      "Breastfeeding among women exposed to antidepressants during pregnancy\n",
      "Pharmacological treatment of unipolar depression during pregnancy and breast-feedingA clinical overview\n",
      "In utero SSRI exposure and risk of clubfoot\n",
      "Motherisk update: New antidepressants in pregnancy\n",
      "Maternal prenatal hair cortisol is associated with prenatal depressive symptom trajectories\n",
      "Teratogenic effects of coadministration of fluoxetine and olanzapine on rat fetuses\n",
      "Are selective serotonin reuptake inhibitors (SSRIS) safe in pregnancy?\n",
      "Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: A population-based cohort study\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.006;    Total Clusters: 226;     Cluster: 144;      Nr of Pubs in Cluster: 83\n",
      "2017.0  3α 5α allo brain fluoxetine allopregnanolone 3α 5α depression kg like treatment ppd rats thp levels mg mg kg antidepressant postpartum ptsd\n",
      "RANDOM TITLES\n",
      "SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake\n",
      "Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder\n",
      "Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain\n",
      "Anhedonia in postpartum rats\n",
      "Antidepressant-like effects of omega-3 fatty acids in postpartum model of depression in rats\n",
      "Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes\n",
      "Menhaden fish oil attenuates postpartum depression in rat model via inhibition of NLRP3-inflammasome driven inflammatory pathway\n",
      "GABA<inf>A</inf> receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment\n",
      "Neurosteroids reduce social isolation-induced behavioral deficits: A proposed link with neurosteroid-mediated upregulation of BDNF expression\n",
      "Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.5_k20_res0.006 **\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k20_res0.006;    Total Clusters: 192;     Cluster: 0;      Nr of Pubs in Cluster: 918\n",
      "2018.0  pregnancy ssri exposure use risk women serotonin ssris depression maternal reuptake serotonin reuptake selective selective serotonin selective serotonin reuptake inhibitors antidepressants reuptake inhibitors fluoxetine ci\n",
      "RANDOM TITLES\n",
      "Selective serotonin reuptake inhibitors and risk for major congenital anomalies\n",
      "Pregnancy outcomes following use of escitalopram: A prospective comparative cohort study\n",
      "Exposure to rosiglitazone and fluoxetine in the first trimester of pregnancy [3]\n",
      "Selective serotonin reuptake inhibitors and autism: additional data on the Quebec Pregnancy/Birth Cohort\n",
      "Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function\n",
      "Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drugs in plasma\n",
      "Maternal Prenatal Depression and Epigenetic Age Deceleration: Testing Potentially Confounding Effects of Prenatal Stress and SSRI Use\n",
      "Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model\n",
      "Use of antidepressants and association with elective termination of pregnancy: Population based case-control study\n",
      "Use of polypharmacotherapy in pregnancy: A prospective outcome in a case\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k20_res0.006;    Total Clusters: 192;     Cluster: 159;      Nr of Pubs in Cluster: 62\n",
      "2014.75  allo 3α brain 5α fluoxetine allopregnanolone 3α 5α depression treatment levels thp neuroactive steroids mice patients kg content induced concentrations mg\n",
      "RANDOM TITLES\n",
      "Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids\n",
      "Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes\n",
      "Neurosteroid secretion in panic disorder\n",
      "Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder\n",
      "Effects of estrogen and progesterone on neuroactive steroids and cytokines in patients with suicidality\n",
      "Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine\n",
      "Neurosteroid biosynthesis down-regulation and changes in GABA<inf>A</inf> receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment\n",
      "Studies on neurosteroids XXVI. Fluoxetine-evoked changes in rat brain and serum levels of neuroactive androgen, 5α-androstane-3α,17β-diol\n",
      "Brexanolone, a neurosteroid antidepressant, vindicates the gabaergic deficit hypothesis of depression and may foster resilience.\n",
      "Kinetics of allopregnanolone formation catalyzed by human 3α-hydroxysteroid dehydrogenase type III (AKR1C2)\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.3_k20_res0.006 **\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.5_k20_res0.005;    Total Clusters: 190;     Cluster: 0;      Nr of Pubs in Cluster: 1025\n",
      "2018.0  pregnancy ssri exposure use risk women serotonin depression ssris maternal reuptake fluoxetine serotonin reuptake selective antidepressants selective serotonin selective serotonin reuptake inhibitors reuptake inhibitors paroxetine\n",
      "RANDOM TITLES\n",
      "Pharmacokinetics of fluoxetine in pregnant baboons (papio spp.)\n",
      "The international prevalence of antidepressant use before, during, and after pregnancy: A systematic review and meta-analysis of timing, type of prescriptions and geographical variability\n",
      "Erratum: Depression and SSRI use in pregnancy associated with traits of autism in children (BMJ (Online) (2014) 349 (g4835) DOI: 10.1136/bmj.g4835)\n",
      "Paroxetine in human milk\n",
      "Association of selective serotonin reuptake inhibitor exposure during pregnancy with speech, scholastic, and motor disorders in offspring\n",
      "Intrauterine Exposure to Antidepressants or Maternal Depressive Symptoms and Offspring Brain White Matter Trajectories From Late Childhood to Adolescence\n",
      "Maternal Antidepressant Use during Pregnancy and the Risk of Attention-Deficit/Hyperactivity Disorder in Children: A Systematic Review of the Current Literature\n",
      "Paroxetine use during pregnancy associated with neonatal intracerebral bleeding\n",
      "Selective serotonin reuptake inhibitor exposure in pregnancy and neonatal adverse events\n",
      "Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition (PLoS ONE (2017) 12: 7 (e0181082) DOI: 10.1371/journal.pone.0181082)\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.005;    Total Clusters: 190;     Cluster: 113;      Nr of Pubs in Cluster: 102\n",
      "2019.0  depression postpartum women treatment ppd postpartum depression postnatal postnatal depression study placebo symptoms fluoxetine pregnancy anxiety antidepressant risk weeks depressive sertraline antidepressants\n",
      "RANDOM TITLES\n",
      "Efficacy of transcranial magnetic stimulation and fluoxetine in the treatment of postpartum depression: A protocol for systematic review and meta-analysis\n",
      "Obsessive-compulsive disorder in the postpartum: Open-label trial of quetiapine augmentation\n",
      "Factors Associated with Depressive and Anxiety Symptom Trajectories Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Individuals\n",
      "Interpersonal therapy versus antidepressant medication for treatment of postpartum depression and anxiety among women with HIV in Zambia: a randomized feasibility trial\n",
      "The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: A double-blind, randomized clinical trial\n",
      "Postnatal depression\n",
      "Trajectories of Depressive and Anxiety Symptoms Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Women\n",
      "Anxiolytic and Anti-depressive Like Effects of Translocator Protein (18 kDa) Ligand YL-IPA08 in a Rat Model of Postpartum Depression\n",
      "Comparing the Effectiveness of Internet Cognitive Behavioral Therapy and Drug Therapy for Treating Postpartum Depression and Children Weight Gain: A Randomized Clinical Trial\n",
      "Development of neuroactive steroids for the treatment of postpartum depression\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.5_k20_res0.005;    Total Clusters: 190;     Cluster: 141;      Nr of Pubs in Cluster: 69\n",
      "2015.0  3α allo brain 5α fluoxetine allopregnanolone 3α 5α depression treatment levels kg ptsd thp mg neuroactive steroids mg kg patients mice content\n",
      "RANDOM TITLES\n",
      "The role of neurosteroids in the anxiolytic, antidepressive- and anticonvulsive effects of selective serotonin reuptake inhibitors\n",
      "Brexanolone, a neurosteroid antidepressant, vindicates the gabaergic deficit hypothesis of depression and may foster resilience.\n",
      "Neurosteroid secretion in panic disorder\n",
      "Recent developments in potential anxiolytic agents targeting GABA <inf>A</inf>/BzR complex or the translocator protein (18kDa) (TSPO)\n",
      "Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids\n",
      "Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase\n",
      "Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes\n",
      "Actions of progesterone on depression-like behavior in a model of surgical menopause are mediated by GABA<inf>A</inf> receptors\n",
      "Effects of estrogen and progesterone on neuroactive steroids and cytokines in patients with suicidality\n",
      "5α-reductase type i expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.5_k20_res0.005 **\n",
      "\n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k20_res0.005;    Total Clusters: 162;     Cluster: 1;      Nr of Pubs in Cluster: 934\n",
      "2018.0  pregnancy ssri exposure use risk women serotonin ssris depression maternal reuptake serotonin reuptake selective selective serotonin selective serotonin reuptake inhibitors antidepressants reuptake inhibitors fluoxetine ci\n",
      "RANDOM TITLES\n",
      "Male Sex Associated With Increased Risk of Neonatal Abstinence Syndrome\n",
      "Possible prenatal impact of sertraline on human placental glutathione S-transferase-π\n",
      "Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment\n",
      "Effects of third trimester fluoxetine exposure on the newborn\n",
      "Maternal selective serotonin reuptake inhibitor use and neurologic effects on the neonate\n",
      "Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors; A prospective controlled multicenter study\n",
      "Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy effects on the infant\n",
      "Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension\n",
      "Use of selective serotonin reuptake inhibitors during pregnancy and risk for autism\n",
      "Depression and SSRI use in pregnancy associated with traits of autism in children\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "==================================================================================================================================\n",
      "Found in alpha0.3_k10_res0.002;    Total Clusters: 147;     Cluster: 2;      Nr of Pubs in Cluster: 1074\n",
      "2018.0  pregnancy ssri exposure use risk women serotonin depression ssris maternal reuptake fluoxetine serotonin reuptake selective selective serotonin antidepressants selective serotonin reuptake inhibitors reuptake inhibitors paroxetine\n",
      "RANDOM TITLES\n",
      "Human amniocytes regulate serotonin levels by active uptake and express genes suggestive of a wider role in facilitating neurotransmitter regulation in the fetal environment\n",
      "Selective serotonin reuptake inhibitors and congenital malformations\n",
      "Characteristics of thiamine uptake by the BeWo human trophoblast cell line\n",
      "Depression during pregnancy\n",
      "Sertraline and desmethylsertraline in human breast milk and nursing infants\n",
      "In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder\n",
      "Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study\n",
      "Nutritional implications of observed neurobehavioral disturbances and reduced gestation length in infants of mothers using selective serotonin reuptake inhibitors during pregnancy [5]\n",
      "Benefits and risks to mother and infant of drug treatment for postnatal depression\n",
      "Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: A population-based cohort study\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "Found in alpha0.3_k10_res0.002;    Total Clusters: 147;     Cluster: 145;      Nr of Pubs in Cluster: 8\n",
      "2020.25  group cbt fluoxetine depression control women infertility infertile infertile women treatment vs intervention pregnancy control group mean scores anxiety therapy study sertraline\n",
      "RANDOM TITLES\n",
      "The effect of antidepressant treatment on the HPA axis, changes in depression score and serum levels of TNF-α in depressed infertile women\n",
      "Pharmacotherapy or Psychotherapy? Selective Treatment Depression in The Infertile Women with Recurrent Pregnancy Loss: A Triple-Arm Randomized Controlled Trial\n",
      "The effect of the cognitive behavioral therapy and pharmacotherapy on infertility stress: A randomized controlled trial\n",
      "Is psychotherapy a reliable alternative to pharmacotherapy to promote the mental health of infertile women? A randomized clinical trial\n",
      "Comparison of pharmacological and nonpharmacological treatment strategies in promotion of infertility self-efficacy scale in infertile women: A randomized controlled trial\n",
      "Treatment of depression and anxiety in infertile women: Cognitive behavioral therapy versus fluoxetine\n",
      "Comparison of midwifery consultation and fluoxetine on ivf outcomes in depressed infertile women: A clinical trial research study\n",
      "Psychiatric intervention improved pregnancy rates in infertile couples\n",
      "- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - \n",
      "** Multiple hits found in parameters: alpha0.3_k10_res0.002 **\n",
      "\n",
      "No hits found for Parameters: \n",
      "set()\n",
      "\n"
     ]
    }
   ],
   "source": [
    "analysis_data_dict = graph_summary_df_dict\n",
    "print_n_random_titles = 10\n",
    "word1 = \"preg\"\n",
    "word2 = \"\"\n",
    "print_word_string = True\n",
    "save_to_file = True\n",
    "file_name = f\"../output/cluster-qualifications/cluster-explorer/ParamsTestTxt/cluster_analysis_output_{word1}.txt\"\n",
    "\n",
    "NetworkAnalyzerUtils().cluster_coherence_analyzer_in_txt(\n",
    "    analysis_data_dict=analysis_data_dict,\n",
    "    print_n_random_titles=print_n_random_titles,\n",
    "    word1=word1,\n",
    "    word2=word2,\n",
    "    print_word_string=print_word_string,\n",
    "    save_to_file=save_to_file,\n",
    "    file_name=file_name,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "# SUICIDE\n",
    "params_scoring_suicide = {\n",
    "    \"alpha0.3_k10_res0.002\": \"1\",\n",
    "    \"alpha0.3_k10_res0.006\": \"0 (too many suicide clusters, very inconsistent)\",\n",
    "    \"alpha0.3_k15_res0.006\": \"1 (very clear singel suicide cluster)\",\n",
    "    \"alpha0.3_k15_res0.01\": \"0 (conflates overdoses and suicide; too many clusters on it; 1 clear)\",\n",
    "    \"alpha0.3_k20_res0.006\": \"1 (one good suicide, one unrelated)\",\n",
    "    \"alpha0.3_k20_res0.01\": \"1 (two clear suicide clusters; should be same)\",\n",
    "    \"alpha0.3_k20_res0.02\": \"0 (akathisia cluster; boderline cluster; no clear bigger suicide cluster)\",\n",
    "    \"alpha0.3_k20_res0.005\": \"1 (very clear singel suicide cluster)\",\n",
    "    \"alpha0.5_k15_res0.006\": \"0 no good suicide cluster\",\n",
    "    \"alpha0.5_k20_res0.006\": \"1 (one clear suicide cluster, one overdose/drug)\",\n",
    "    \"alpha0.5_k20_res0.01\": \"0 first biggest cluster is very bad\",\n",
    "}\n",
    "# pregnancy\n",
    "params_scoring_pregnancy = {\n",
    "    \"alpha0.3_k10_res0.002\": \"1 (single cluster, coherent)\",\n",
    "    \"alpha0.3_k10_res0.006\": \"0 (pharma pregnancy, narcolepsy, lectation, neonatal, TOO MANY)\",\n",
    "    \"alpha0.3_k15_res0.006\": \"0 (4 clusters, not one clear preggo cluster)\",\n",
    "    \"alpha0.3_k15_res0.01\": \"0 (1 big trash topic; pretty bad)\",\n",
    "    \"alpha0.3_k20_res0.006\": \"0 (one small preggo cluster)\",\n",
    "    \"alpha0.3_k20_res0.01\": \"1 (bit too split up, but sensical, [pretty good])\",\n",
    "    \"alpha0.3_k20_res0.02\": \"0 (creation seems wieird.)\",\n",
    "    \"alpha0.3_k20_res0.005\": \"1 (single cluster, coherent)\",\n",
    "    \"alpha0.5_k15_res0.006\": \"0 (biggest cluster sucks. creation went weird)\",\n",
    "    \"alpha0.5_k20_res0.006\": \"0 (first biggest cluster is weird)\",\n",
    "    \"alpha0.5_k20_res0.01\": \"0 (small cluster, seem sensical tho)\",\n",
    "}"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# last_selection_params\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Params: alpha0.3_k10_res0.002; Nr of clusters: 147\n",
      "##################################################\n",
      "Params: alpha0.3_k15_res0.004; Nr of clusters: 177\n",
      "##################################################\n",
      "Params: alpha0.3_k20_res0.005; Nr of clusters: 162\n",
      "##################################################\n",
      "Params: alpha0.3_k20_res0.006; Nr of clusters: 192\n",
      "##################################################\n"
     ]
    }
   ],
   "source": [
    "iterations = -1  # until a partition is not an improvement over the previous one\n",
    "graph_summary_df_dict = {}\n",
    "\n",
    "last_selection_params = [\n",
    "    \"alpha0.3_k10_res0.002\",\n",
    "    \"alpha0.3_k15_res0.004\",\n",
    "    \"alpha0.3_k20_res0.005\",\n",
    "    \"alpha0.3_k20_res0.006\",\n",
    "]\n",
    "\n",
    "\n",
    "for params in last_selection_params:\n",
    "    G = params_graph_dict[params.split(\"_res\")[0]]\n",
    "    resolution = pd.to_numeric(params.split(\"res\")[1])\n",
    "    column_name = f\"cluster_{params}\"\n",
    "    pc = PartitionCreator(G, df)\n",
    "    pc.create_partition_from_cmpvertexpartition(\n",
    "        n_iterations=iterations,\n",
    "        resolution_parameter=resolution,\n",
    "        verbose=False,\n",
    "        cluster_column_name=column_name,\n",
    "        centrality_column_name=f\"centrality_{params}\",\n",
    "    )\n",
    "    #############################\n",
    "    #############################\n",
    "    ce = CommunityExplorer(\n",
    "        df=pc.df,\n",
    "        cluster_column=f\"cluster_{params}\",\n",
    "        sort_column=f\"centrality_{params}\",\n",
    "        nr_tiles=15,\n",
    "    )\n",
    "    ce.create_full_explorer()\n",
    "    df_summary, cluster_titles_sheets_dict = ce.full_return()\n",
    "\n",
    "    # save to excel\n",
    "    filepath = f\"../output/cluster-qualifications/cluster-explorer/FinalSelect/SingleSolExplorer_{params}.xlsx\"\n",
    "    NetworkAnalyzerUtils().clusters_excel_saver_with_hyperlinks(\n",
    "        filepath, df_summary, cluster_titles_sheets_dict\n",
    "    )\n",
    "    print(f\"Params: {params}; Nr of clusters: {len(pc.partition.sizes())}\")\n",
    "    print(\"#\" * 50)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# FINAL SELECTION\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## alpha0.3_k10_res0.002; Nr of clusters: 154\n",
    "\n",
    "1. \"alpha0.3_k10_res0.002\": \"1 - suicide\",\n",
    "2. \"alpha0.3_k10_res0.002\": \"1 (single cluster, coherent) - pregnancy\",\n",
    "\n",
    "##### EVAL TOP 5 CLSUTERS\n",
    "\n",
    "0. Very clear memory clsuter; pharma and not; 1199 pubs\n",
    "1. Receptor binding; brain; guess its good\n",
    "2. QTC prolongation; cardiovascular; good\n",
    "3. astrocytes; pharma; good\n",
    "4. Binding; platelets check difference to 2; (kinda good)\n",
    "5. Pulmonary hypertension; bluthochdruck; (kinda good)\n",
    "\n",
    "## alpha0.3_k20_res0.01; Nr of clusters: 299\n",
    "\n",
    "1. \"alpha0.3_k20_res0.01\": \"1 (two clear suicide clusters; should be same) - suicide\",\n",
    "2. \"alpha0.3_k20_res0.01\": \"1 (bit too split up, but sensical, [pretty good]) - pregnancy\",\n",
    "3. Good elderly cluster\n",
    "4. Good Fall cluster (in elderly)\n",
    "5. Good single seasonal cluster\n",
    "6. good withdrawal/discontinuation cluster\n",
    "\n",
    "##### EVAL TOP 5 CLSUTERS\n",
    "\n",
    "0. Learning; Memory;hippocampus; fear (avoidance learning); Ok Good\n",
    "1. Prolactin; Pharmacology; ok Good\n",
    "2. Cardiac,arrythmia, qt prolongation (very good)\n",
    "3. pregnancy; placenta, a preggo pharma cluster\n",
    "4. SSRI mechanisms; Pharmacology; Depression treatment\n",
    "5. Pharmacology; 5-HT; receptor; SERT(serotonintransporter),\n",
    "\n",
    "## alpha0.3_k20_res0.006; Nr of clusters: 190\n",
    "\n",
    "1. \"alpha0.3_k20_res0.01\": \"1 (two clear suicide clusters; should be same)- suicide\",\n",
    "2. \"alpha0.3_k20_res0.01\": \"1 (bit too split up, but sensical, [pretty good])- pregnancy\",\n",
    "\n",
    "##### EVAL TOP 5 CLSUTERS\n",
    "\n",
    "0. Memory; Cognition; Learning;\n",
    "1. Receptor; Animal studies; IN vivo; autoreceptor;\n",
    "2. cardiac; qt prolongation\n",
    "3. astrocytes; pharmaco\n",
    "4. pharmacological ssri properties; 5 ht; receptors\n",
    "5. vascular; rat; unclear;\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = pd.read_pickle(\"../data/04-embeddings/df_with_specter2_embeddings.pkl\")\n",
    "\n",
    "df[\"title_abstract\"] = df.apply(\n",
    "    lambda x: (\n",
    "        x[\"title\"] + \". \" + str(x[\"abstract\"])\n",
    "        if pd.notnull(x[\"abstract\"])\n",
    "        else x[\"title\"]\n",
    "    ),\n",
    "    axis=1,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of clusters: 147\n",
      "Quality: 352705.7008721407\n",
      "Params: alpha0.3_k10_res0.002; Nr of clusters: 147\n",
      "##################################################\n",
      "Number of clusters: 177\n",
      "Quality: 448758.81664172356\n",
      "Params: alpha0.3_k15_res0.004; Nr of clusters: 177\n",
      "##################################################\n",
      "Number of clusters: 162\n",
      "Quality: 556552.0537528489\n",
      "Params: alpha0.3_k20_res0.005; Nr of clusters: 162\n",
      "##################################################\n",
      "Number of clusters: 192\n",
      "Quality: 540447.026344425\n",
      "Params: alpha0.3_k20_res0.006; Nr of clusters: 192\n",
      "##################################################\n"
     ]
    }
   ],
   "source": [
    "\"\"\"\n",
    "This code chunk performs community detection on a graph using different parameter configurations. It iterates over a list of parameter strings, extracts the necessary values from each string, and creates a partition based on the graph and the extracted parameters. It then drops unnecessary columns from the partition's dataframe, adds cluster labels to the graph, and saves the resulting graph as a GraphML file. Finally, it saves the partition's dataframe as a pickle file.\n",
    "\"\"\"\n",
    "\n",
    "final_params_list = [\n",
    "    \"alpha0.3_k10_res0.002\",\n",
    "    \"alpha0.3_k15_res0.004\",\n",
    "    \"alpha0.3_k20_res0.005\",\n",
    "    \"alpha0.3_k20_res0.006\",\n",
    "]\n",
    "iterations = -1  # until not improved anymore\n",
    "\n",
    "for params in final_params_list:\n",
    "    G = params_graph_dict[params.split(\"_res\")[0]]\n",
    "    resolution = pd.to_numeric(params.split(\"res\")[1])\n",
    "    pc = PartitionCreator(G, df)\n",
    "    pc.create_partition_from_cmpvertexpartition(\n",
    "        n_iterations=iterations,\n",
    "        resolution_parameter=resolution,\n",
    "        verbose=True,\n",
    "        cluster_column_name=f\"cluster_{params}\",\n",
    "        centrality_column_name=f\"centrality_{params}\",\n",
    "    )\n",
    "\n",
    "    # save graphml\n",
    "    pc.G.write_graphml(f\"../data/07-clustered-graphs/{params}.graphml\")\n",
    "    path = f\"../data/06-clustered-df/{params}.pkl\"\n",
    "    pc.df.to_pickle(path)\n",
    "    #############################\n",
    "    #############################\n",
    "    ce = CommunityExplorer(\n",
    "        df=pc.df,\n",
    "        cluster_column=f\"cluster_{params}\",\n",
    "        sort_column=f\"centrality_{params}\",\n",
    "        nr_tiles=20,\n",
    "    )\n",
    "    ce.create_full_explorer()\n",
    "    df_summary, cluster_titles_sheets_dict = ce.full_return()\n",
    "\n",
    "    # save to excel\n",
    "    filepath = f\"../output/cluster-qualifications/cluster-explorer/FinalSelect/SingleSolExplorer_{params}.xlsx\"\n",
    "    NetworkAnalyzerUtils().clusters_excel_saver_with_hyperlinks(\n",
    "        filepath, df_summary, cluster_titles_sheets_dict\n",
    "    )\n",
    "    print(f\"Params: {params}; Nr of clusters: {len(pc.partition.sizes())}\")\n",
    "    print(\"#\" * 50)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# After Qualitative Assessment We Choose:\n",
    "\n",
    "# Params: alpha0.3_k10_res0.002\n",
    "\n",
    "## now we run it a final time with varying iterations\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of clusters: 147\n",
      "Quality: 352705.7008721407\n",
      "Iterations: -1\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n",
      "Number of clusters: 143\n",
      "Quality: 351471.61429731455\n",
      "Iterations: 2\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n",
      "Number of clusters: 147\n",
      "Quality: 352156.52251189604\n",
      "Iterations: 6\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n",
      "Number of clusters: 148\n",
      "Quality: 352215.99889878754\n",
      "Iterations: 10\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n",
      "Number of clusters: 147\n",
      "Quality: 352711.1350013889\n",
      "Iterations: 50\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n",
      "Number of clusters: 148\n",
      "Quality: 352776.7223749008\n",
      "Iterations: 100\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n",
      "Number of clusters: 149\n",
      "Quality: 352803.4240432005\n",
      "Iterations: 200\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n",
      "Number of clusters: 149\n",
      "Quality: 352811.8306709937\n",
      "Iterations: 400\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n",
      "Number of clusters: 149\n",
      "Quality: 352829.0796258901\n",
      "Iterations: 800\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n"
     ]
    }
   ],
   "source": [
    "params = \"alpha0.3_k10_res0.002\"\n",
    "iterations = [-1, 2, 6, 10, 50, 100, 200, 400, 800]\n",
    "quality_values = {}\n",
    "for i in iterations:\n",
    "    G = params_graph_dict[params.split(\"_res\")[0]]\n",
    "    resolution = pd.to_numeric(params.split(\"res\")[1])\n",
    "    pc = PartitionCreator(G, df)\n",
    "    pc.create_partition_from_cmpvertexpartition(\n",
    "        n_iterations=i,\n",
    "        resolution_parameter=resolution,\n",
    "        verbose=True,\n",
    "        cluster_column_name=f\"cluster_{params}\",\n",
    "        centrality_column_name=f\"centrality_{params}\",\n",
    "    )\n",
    "    quality_values[i] = pc.partition.quality()\n",
    "    # save graphml\n",
    "    pc.G.write_graphml(f\"../data/07-clustered-graphs/{params}.graphml\")\n",
    "    path = f\"../data/06-clustered-df/{params}.pkl\"\n",
    "    pc.df.to_pickle(path)\n",
    "    #############################\n",
    "    #############################\n",
    "    ce = CommunityExplorer(\n",
    "        df=pc.df,\n",
    "        cluster_column=f\"cluster_{params}\",\n",
    "        sort_column=f\"centrality_{params}\",\n",
    "        nr_tiles=20,\n",
    "    )\n",
    "    ce.create_full_explorer()\n",
    "    df_summary, cluster_titles_sheets_dict = ce.full_return()\n",
    "\n",
    "    # save to excel\n",
    "    filepath = f\"../output/cluster-qualifications/cluster-explorer/FinalSelect/SingleSolExplorer_{params}.xlsx\"\n",
    "    NetworkAnalyzerUtils().clusters_excel_saver_with_hyperlinks(\n",
    "        filepath, df_summary, cluster_titles_sheets_dict\n",
    "    )\n",
    "    print(f\"Iterations: {i}\")\n",
    "    print(f\"Params: {params}\")\n",
    "    print(\"#\" * 50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [],
   "source": [
    "p = \"../output/tables/descriptives/leiden_quality_vs_iterations.csv\"\n",
    "dfquality = pd.DataFrame(quality_values.items(), columns=[\"iterations\", \"quality\"])\n",
    "dfquality.to_csv(p, index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Data Preparation (Assuming you already have quality_values and iterations)\n",
    "iterations = list(quality_values.keys())\n",
    "quality = list(quality_values.values())\n",
    "\n",
    "# Plotting with Enhanced Visuals\n",
    "plt.figure(figsize=(10, 6))  # Adjust figure size for better readability\n",
    "\n",
    "# Use scatter plot for discrete data points\n",
    "plt.scatter(\n",
    "    iterations, quality, marker=\"o\", color=\"skyblue\", label=\"Quality\"\n",
    ")  # Add labels for the legend\n",
    "\n",
    "# Add a line plot to visualize the trend\n",
    "plt.plot(\n",
    "    iterations, quality, color=\"lightcoral\", linestyle=\"-\", alpha=0.7\n",
    ")  # Line plot with transparency\n",
    "\n",
    "plt.xlabel(\"Iterations\", fontsize=12)\n",
    "plt.ylabel(\"Quality\", fontsize=12)\n",
    "plt.title(\"Quality over Iterations\", fontsize=14)\n",
    "\n",
    "# Improved Tick Labels and Gridlines\n",
    "plt.yticks(fontsize=10)\n",
    "plt.grid(axis=\"y\", linestyle=\"--\")  # Add subtle gridlines for better readability\n",
    "\n",
    "# Legend\n",
    "plt.legend()\n",
    "\n",
    "# Save Figure\n",
    "output_path = (\n",
    "    \"../output/figures/leiden_iterations_quality_plot_alpha0.3_k10_res0.002.png\"\n",
    ")\n",
    "plt.savefig(output_path, dpi=300)  # Save high-resolution figure\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Safe final partition with 200 iterations\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of clusters: 149\n",
      "Quality: 352803.4240432005\n",
      "Iterations: 200\n",
      "Params: alpha0.3_k10_res0.002\n",
      "##################################################\n"
     ]
    }
   ],
   "source": [
    "params = \"alpha0.3_k10_res0.002\"\n",
    "iterations = 200\n",
    "quality_values = {}\n",
    "G = params_graph_dict[params.split(\"_res\")[0]]\n",
    "resolution = pd.to_numeric(params.split(\"res\")[1])\n",
    "pc = PartitionCreator(G, df)\n",
    "pc.create_partition_from_cmpvertexpartition(\n",
    "    n_iterations=iterations,\n",
    "    resolution_parameter=resolution,\n",
    "    verbose=True,\n",
    "    cluster_column_name=f\"cluster_{params}\",\n",
    "    centrality_column_name=f\"centrality_{params}\",\n",
    ")\n",
    "# save graphml\n",
    "pc.G.write_graphml(f\"../data/07-clustered-graphs/{params}.graphml\")\n",
    "path = f\"../data/06-clustered-df/{params}.pkl\"\n",
    "pc.df.to_pickle(path)\n",
    "#############################\n",
    "#############################\n",
    "ce = CommunityExplorer(\n",
    "    df=pc.df,\n",
    "    cluster_column=f\"cluster_{params}\",\n",
    "    sort_column=f\"centrality_{params}\",\n",
    "    nr_tiles=20,\n",
    ")\n",
    "ce.create_full_explorer()\n",
    "df_summary, cluster_titles_sheets_dict = ce.full_return()\n",
    "\n",
    "# save to excel\n",
    "filepath = f\"../output/cluster-qualifications/cluster-explorer/FinalSelect/DELFinalRun_i{iterations}_SingleSolExplorer_{params}.xlsx\"\n",
    "NetworkAnalyzerUtils().clusters_excel_saver_with_hyperlinks(\n",
    "    filepath, df_summary, cluster_titles_sheets_dict\n",
    ")\n",
    "filepath = f\"../output/cluster-qualifications/cluster-explorer/FinalSelect/SingleSolExplorer_{params}.xlsx\"\n",
    "NetworkAnalyzerUtils().clusters_excel_saver_with_hyperlinks(\n",
    "    filepath, df_summary, cluster_titles_sheets_dict\n",
    ")\n",
    "print(f\"Iterations: {iterations}\")\n",
    "print(f\"Params: {params}\")\n",
    "print(\"#\" * 50)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
